Francis Farraye | Profiles RNS

Francis A. Farraye, MD

Adjunct Professor

Boston University Chobanian & Avedisian School of Medicine

Medicine

Gastroenterology

MD, Albert Einstein College of Medicine
MSc, Harvard School of Public Health
BS, Stony Brook University

Websites

	Mayo Clinic
	Google Scholar
	ResearchGate

ORCID : 0000-0001-6371-2441

Dr. Farraye is a Senior Associate Consultant in the Section of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville Florida where he co-directs the Inflammatory Bowel Disease Center. Prior to relocating in 2019, he was Clinical Director in the Section of Gastroenterology and the Inflammatory Bowel Disease Center at Boston Medical Center. At Chobanian and Avedisian School of Medicine, he was Professor of Medicine. Dr. Farraye earned his medical doctorate from the Albert Einstein College of Medicine in New York and his master's degree in Epidemiology from the Harvard School of Public Health.

Dr. Farraye's clinical interests are in the care of patients with inflammatory bowel disease. He is currently investigating C. difficile infection in IBD patients, the management and diagnosis of dysplasia and cancer in patients with IBD; social media use and health literacy in IBD patients; hepatitis B vaccination efficacy in patients with IBD; and subclinical hepatic fibrosis in patients with IBD.

A frequent speaker and invited lecturer on topics on the diagnosis and management of inflammatory bowel disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, book chapters, reviews, and abstracts. He is the series editor for the text Curbside Consultations in Gastroenterology and co-edited the text, Curbside Consultation in Inflammatory Bowel Disease and Gastrointestinal Emergencies. His books for patients include Questions and Answers about Ulcerative Colitis, Questions and Answers about Crohn's Disease and Ulcerative Colitis for Dummies.

Dr. Farraye is a Fellow of the American Society of Gastrointestinal Endoscopy, American Gastroenterological Association and the American College of Gastroenterology. He has served on numerous national and international committees including as a member of the ACG Board of Trustees. He is co-chair of the Crohn's and Colitis Foundation Membership Committee and a member of the Chapter Medical Advisory Committee for the New England Crohn's and Colitis Foundation and a past chairman. The New England Crohn's and Colitis Foundation named Dr. Farraye Humanitarian of the Year in 2003. In 2009, the ACG awarded Dr. Farraye the William Carey Award for service to the college. Dr. Farraye has been recognized as "Top Doctor" in Gastroenterology by Boston Magazine and U.S. News and World Report since 2010.

Member
Boston University
Center for Regenerative Medicine

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research

BU Research
BMC Research

A Phase III, Open-Label Study to Determine the Long-Term Safety and Efficacy of Vedolizumab (MLN0002) in Patients with Ulcerative Colitis and Crohn's Disease
04/01/2009 - 09/30/2017 (PI)
Millennium Pharmaceuticals, Inc.

PUCCINI-Prospective Cohort of Ulcerative Colitis and Crohn's Disease Patients Undergoing Surgery to Identify Risk Factors for Post-Operative Infection I
06/23/2014 - 07/01/2017 (Subcontract PI)
Icahn School of Medicine at Mount Sinai Crohns & Colitis Fdn

A Study to Assess the Association of Clinical outcome with serum drug concentration levels and anti-drug antibody in moderately to severely active Crohn's Disease patients treated with Adalimumab prot
08/01/2011 - 07/31/2012 (PI)
Prometheus Laboratories, Inc.

PROCUREMENT OF BLOOD SAMPLES FROM IBD, GI CONTROLS AND HEALTHY VOLUN TEER SUBJECTS FOR USE IN THE
01/01/2011 - 12/31/2011 (PI)
Prometheus Laboratories, Inc.

C13006, A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study for the Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients with Modera
04/01/2009 - 05/31/2011 (PI)
Millennium Pharmaceuticals, Inc.

C13007, A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study for the Induction and Maintenance of Clinical Response and Remission by Vedolizuamb (MLN0002) in Patients with Modera
04/01/2009 - 05/31/2011 (PI)
Millennium Pharmaceuticals, Inc.

A Phase IIIb Multi-Center, Double-Blind, Placebo-Controlled, Randomized Trial to Examine the Corticosteroid-Sparing Effects of Certolizumab Pegol in Patients with Moderate to Severe Crohn’s Disease (COSPAR I)
11/06/2006 - 11/05/2008 (PI)
UCB Pharma, Inc.

A Multi-Center, Open-Label Treatment Protocol of the Human Anti-TNF Monoclonal Antibody Adalimumab in Patients with Moderate to Severe Crohn’s Disease with Previous Exposure to Infliximab
12/08/2006 - 06/07/2007 (PI)
Abbott Laboratories

A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Oral IL-12/23 Inhibitor, STA-5326 Mesylate for the Induction of Clinical Response in Patients with Crohn’s Disease
10/06/2005 - 10/05/2006 (PI)
Synta Pharmaceuticals Corporation

An Eight-Week, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate Efficacy and Safety of Talnetant in Subjects with Irritable Bowel Syndrome
11/04/2004 - 07/19/2005 (PI)
GlaxoSmithKline, Inc.

Showing 10 of 14 results. Show All Results

Entyvio (velolizumab) long-term safety study
04/12/2016 - 06/30/2023 (Multi-PI)
PI: Francis A. Farraye, MD
Takeda Pharmaceuticals

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Invest to Invest…
10/03/2016 - 10/02/2019 (PI)
Celgene Corporation

EH-5151- Evaluating the Nutritional Impact of Serum-Derived Bovine Immunoglobulin / Protein Isola…
07/25/2016 - 07/24/2019 (PI)
Entera Health, Inc.

IBD-600 Registry
09/19/2018 - 03/31/2019 (PI)
Corrona, LLC

An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Ac…
10/08/2015 - 09/30/2018 (PI)
Takeda Pharmaceuticals

Sample Collection Study to Evaluate DNA Markers in Subjects with Inflammatory Bowel Disease (IBD)…
12/22/2014 - 10/10/2017 (PI)
Exact Sciences

Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease:OCEANIA Study
12/12/2014 - 06/30/2017 (PI)
Exact Sciences

A Prospective, Randomized,Double Blinded, Placebo-Controlled Phase II Clinical Study of Trichuris…
05/01/2014 - 12/31/2015 (PI)
Duke University NIH-NIAID

Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease
12/20/2012 - 09/01/2015 (PI)
Cubist Pharmaceuticals Inc

Methotrexate Response in Treatment of UC - MERIT-UC
08/15/2011 - 01/31/2014 (PI)
University of North Carolina NIH-NIDDK

Showing 10 of 13 results. Show All Results

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Karime C, Farraye FA, Hashash JG. Use of Immune Checkpoint Inhibitors in Patients With Inflammatory Bowel Disease After Ileal Pouch-Anal Anastomosis. Inflamm Bowel Dis. 2024 Apr 03; 30(4):681-685. PMID: 37260345

Hashash JG, Yu Ci Ng F, Farraye FA, Wang Y, Colucci DR, Baxi S, Muneer S, Reddan M, Shingru P, Melmed GY. Inter- and Intraobserver Variability on Endoscopic Scoring Systems in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis. Inflamm Bowel Dis. 2024 Mar 28. PMID: 38547325

Smith RA, Desai A, Barnes EL, Hayney M, Kochhar GS, Hashash JG, Farraye FA, Caldera F. Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus. Am J Gastroenterol. 2024 Mar 21. PMID: 38318981

Brenner EJ, Weaver KN, Zhang X, Kastl AJ, Strople JA, Adler J, Dubinsky MC, Bousvaros A, Watkins R, Dai X, Chen W, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda EA, Farraye FA, Chun KY, Zikry M, Bastidas M, Firestine A, Craig RG, Boccieri ME, Long MD, Kappelman MD. Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2024 Feb 17. PMID: 38369224

Kastl AJ, Weaver KN, Zhang X, Strople JA, Adler J, Kelsen JR, Dubinsky MC, Bousvaros A, Watkins R, Dai C, Cross RK, Higgins PDR, Ungaro R, Bewtra M, Bellaguarda EA, Farraye FA, Chun K, Zikry M, Bastidas M, Boccieri ME, Firestine A, Long MD, Kappelman MD. Humoral immune response and safety of SARS-CoV-2 vaccination in very early onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2024 Apr; 78(4):871-877. PMID: 38356293

Caldera F, Rolak S, Farraye FA, Necela BM, Cogen D, Zona EE, Schell TL, Ramirez OR, Almasry M, Chun K, Hayney MS, Knutson KL. Higher and Sustained Cell-Mediated Immune Responses after Three Doses of mRNA COVID-19 Vaccine In Patients with Inflammatory Bowel Disease on Anti-TNF Therapy. Clin Transl Gastroenterol. 2024 Feb 13. PMID: 38349178

Odah T, Karime C, Hashash JG, Farraye FA. Nintedanib-Induced Colitis Can Mimic Inflammatory Bowel Disease. ACG Case Rep J. 2024 Feb; 11(2):e01282. PMID: 38333722; PMCID: PMC10852397; DOI: 10.14309/crj.0000000000001282;

Farraye FA. Reviewing Recommendations for Vaccines and Health Care Maintenance in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2024 Feb; 20(2):115-118. PMID: 38414913; PMCID: PMC10895912

Karime C, Crosby S, Bhat S, Hashash JG, Farraye FA. Rapid Adoption of Pneumococcal 20-Valent Conjugate Vaccination in Adult Patients With Inflammatory Bowel Disease: An Analysis One Year After Availability. J Clin Gastroenterol. 2024 Feb 01; 58(2):207-209. PMID: 38047595

Siu RK, Karime C, Hashash JG, Kinnucan J, Picco MF, Farraye FA. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease. Crohns Colitis 360. 2024 Jan; 6(1):otae007. PMID: 38352117; PMCID: PMC10862649; DOI: 10.1093/crocol/otae007;

Showing 10 of 474 results. Show More

Bucobo JC, Kassim O, Konijeti GG, Abraham BP, Abegunde AT, Farraye FA, Guha S, Kowalski T, Kumar A, Markowitz AJ, Schoeppner HL, Tierney WM. Role of the industry representative in the practice of gastroenterology and GI endoscopy. Gastrointest Endosc. 2024 Mar; 99(3):307-313. PMID: 38260918

Desai A, Hashash JG, Kochhar GS, Hayney MS, Caldera F, Farraye FA. Recombinant Zoster Vaccine (RZV) is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study. J Crohns Colitis. 2024 Jan 15. PMID: 38224526

Bali AS, Hashash JG, Farraye FA. Response to Benson et al. Am J Gastroenterol. 2024 Jan 01; 119(1):214-215. PMID: 38174915

Suilik HA, Jaber F, Abuelazm M, Ramadan A, Elzeftawy MA, Elrosasy A, Youssef RA, Abdelazeem B, Hashash JG, Farraye FA, Ghoz H. Sphingosine 1-phosphate (S1P) receptor modulators as an induction and maintenance therapy for ulcerative colitis: a systematic review and meta-analysis of randomized controlled trials. Inflamm Res. 2024 Feb; 73(2):183-198. PMID: 38153524

Beniwal-Patel P, Waclawik G, Browning K, Urmat A, Schell TL, Smith R, Huerta A, Hipp L, Dave S, Shah N, Dillon KE, Reiter-Schreurs K, Russ RK, Mailig MA, Osman F, Farraye FA, Weiss J, Hayney MS, Caldera F. Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel Disease. Crohns Colitis 360. 2023 Oct; 5(4):otad078. PMID: 38130948; PMCID: PMC10734681; DOI: 10.1093/crocol/otad078;

Hashash JG, Mourad FH, Odah T, Farraye FA, Kroner P, Stocchi L. Ethnic Variation Trends in the Use of Ileal Pouch-Anal Anastomosis in Patients With Ulcerative Colitis. Crohns Colitis 360. 2023 Oct; 5(4):otad072. PMID: 38034883; PMCID: PMC10686008; DOI: 10.1093/crocol/otad072;

Kuriakose Kuzhiyanjal AJ, Nigam GB, Antoniou GA, Farraye FA, Cross RK, Limdi JK. Management of Inflammatory Bowel Disease Using E-health Technologies: A Systematic Review and Meta-Analysis. J Crohns Colitis. 2023 Nov 08; 17(10):1596-1613. PMID: 37099723; PMCID: PMC10637047; DOI: 10.1093/ecco-jcc/jjad075;

Motwani KK, Hashash JG, Farraye FA, Kappelman MD, Weaver KN, Zhang X, Long MD, Cross RK. Impact of Holding Immunosuppressive Therapy in Patients with Inflammatory Bowel Disease Around mRNA COVID-19 Vaccine Administration on Humoral Immune Response and Development of COVID-19 Infection. J Crohns Colitis. 2023 Nov 08; 17(10):1681-1688. PMID: 37232444

Smith RA, Desai A, Hashash JG, Hayney MS, Farraye FA, Caldera F. Addressing the Risks of Respiratory Syncytial Virus for Patients With Inflammatory Bowel Disease in the Era of Novel Vaccines. Inflamm Bowel Dis. 2023 Nov 02; 29(11):1842-1845. PMID: 37816231

Itzkowitz S, Farraye FA, Limburg PJ, Gagrat Z, Olson MC, Zella J, Kisiel JB. Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study. J Crohns Colitis. 2023 Oct 20; 17(9):1436-1444. PMID: 37166153; PMCID: PMC10588779; DOI: 10.1093/ecco-jcc/jjad069;

Caldera F, Richard L, Almasry M, Phan H, Chun K, Farraye FA, Hayney MS. Persistence of Antibodies Six Months after Three COVID-19 mRNA Vaccine Doses in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Oct 03; 29(10):1662-1666. PMID: 36788133

Desai A, Deepak P, Cross RK, Murone J, Farraye FA, Ungaro RC, Kochhar GS. Effect of 2 vs 3 Doses of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease: A Population-based Propensity Matched Analysis. Inflamm Bowel Dis. 2023 Oct 03; 29(10):1563-1571. PMID: 36576102

Schell TL, Ramirez O, Almasry M, Farraye FA, Hayney MS, Caldera F. Additional COVID-19 Booster Doses Increase Anti-spike Serum Antibody Concentrations Among Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Oct 03; 29(10):e38-e39. PMID: 37071782

Yang MM, Usiskin K, Ahmad HA, Ather S, Sreih A, Canavan JB, Farraye FA, Ma C. Considerations for Colorectal Neoplasia Detection in Inflammatory Bowel Disease Clinical Trials. Dig Dis. 2024; 42(1):12-24. PMID: 37757769; PMCID: PMC10836758; DOI: 10.1159/000533395;

Santiago P, Coelho-Prabhu N, Lennon R, Rui S, Rajauria P, Friton J, Raffals LE, Deepali F, Daoud N, Farraye FA, Tuck J, Malik T, Leleiko NS, Shapiro J, Shah SA, Sands BE, Ungaro RC. Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway. Am J Gastroenterol. 2024 Jan 01; 119(1):147-154. PMID: 37713528

Desai A, Hashash JG, Kochhar GS, Farraye FA. Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study. Crohns Colitis 360. 2023 Jul; 5(3):otad047. PMID: 37680248; PMCID: PMC10482141; DOI: 10.1093/crocol/otad047;

El Hage Chehade N, Ghoneim S, Shah S, Pardi DS, Farraye FA, Francis FF, Hashash JG. Efficacy and Safety of Vedolizumab and Tumor Necrosis Factor Inhibitors in the Treatment of Steroid-refractory Microscopic Colitis: A Systematic Review and Meta-analysis. J Clin Gastroenterol. 2023 Sep 04. PMID: 37668427

Loeb L, Nasir A, Picco MF, Hashash JG, Kinnucan JA, Farraye FA. Prior Authorization of Biologics in the Management of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Sep 01; 29(9):e37. PMID: 37196096

Desai A, Soni A, Hayney MS, Hashash JG, Kochhar GS, Farraye FA, Caldera F. Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study. Inflamm Bowel Dis. 2023 Aug 04. PMID: 37540900

Caldera F, Farraye FA, Necela BM, Cogen D, Saha S, Wald A, Daoud ND, Chun K, Grimes I, Lutz M, Van Helden SR, Swift MD, Virk A, Bharucha AE, Patel TC, Gores GJ, Chumsri S, Hayney MS, Knutson KL. Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination. Inflamm Bowel Dis. 2023 Aug 01; 29(8):1202-1209. PMID: 36103273; PMCID: PMC9494450; DOI: 10.1093/ibd/izac193;

Gaidos JKJ, Al Bawardy B, Farraye FA, Regueiro M. Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice. Crohns Colitis 360. 2023 Jul; 5(3):otad037. PMID: 37559746; PMCID: PMC10407976; DOI: 10.1093/crocol/otad037;

Singer D, Thompson-Leduc P, Gupta D, Poston S, Cheng WY, Ma S, Pawlowski JE, Duh MS, Devine F, Banatwala A, Bernstein E, Farraye FA. Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United States. Crohns Colitis 360. 2023 Jul; 5(3):otad033. PMID: 37497018; PMCID: PMC10368335; DOI: 10.1093/crocol/otad033;

Desai A, Hashash JG, Baker G, Farraye FA, Waghray N, Kochhar GS. Effect of Bariatric Surgery on Disease Outcomes in Patients with Inflammatory Bowel Disease: A US-based Propensity Matched Cohort Study. J Clin Gastroenterol. 2023 Jun 27. PMID: 37390044

Karime C, Hashash JG, Picco MF, Craver EC, Murray JA, Farraye FA. The Effect of Renin-Angiotensin-Aldosterone System Blocking Agents on the Long-term Disease Course of Patients With Crohn's Disease. J Clin Gastroenterol. 2023 Jun 26. PMID: 37389966

Koop AH, Travers PM, Khanna S, Pardi DS, Farraye FA, Hashash JG. Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2023 Nov; 38(11):1910-1916. PMID: 37337469

Kochhar GS, Desai A, Farraye FA, Cross RK, El-Hachem S, Dulai PS, Regueiro M. Efficacy of biologic and small molecule agents as second-line therapy after exposure to TNF inhibitors in patients with ulcerative colitis: A propensity-matched cohort study. Aliment Pharmacol Ther. 2023 Aug; 58(3):297-308. PMID: 37300328

Caldera F, Spaulding AC, Hayney MS, Farraye FA. Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation? Authors' reply. Aliment Pharmacol Ther. 2023 Jun; 57(11):1345-1346. PMID: 37161632

Chase RC, Tamim H, Sheikh WGE, Clift K, Bruining D, Ha C, Farraye FA, Hashash JG. Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease. Ann Gastroenterol. 2023; 36(4):423-429. PMID: 37396005; PMCID: PMC10304528; DOI: 10.20524/aog.2023.0807;

Karime C, Hashash JG, Farraye FA. Measuring of Postvaccination Hepatitis B Titers in Patients With Inflammatory Bowel Disease: Thoughts for Further Investigation. Clin Gastroenterol Hepatol. 2024 Jan; 22(1):201-202. PMID: 37187325

El Hage Chehade N, Ghoneim S, Shah S, Chahine A, Mourad FH, Francis FF, Binion DG, Farraye FA, Hashash JG. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Inflamm Bowel Dis. 2023 May 02; 29(5):808-817. PMID: 35766805

Singer D, Thompson-Leduc P, Gupta D, Cheng WY, Poston S, Ma S, Pawlowski JE, Duh MS, Morris ED, Devine F, Farraye FA. Incidence and risk of herpes zoster in patients with ulcerative colitis and Crohn's disease in the USA. Gastroenterol Rep (Oxf). 2023; 11:goad016. PMID: 37064550; PMCID: PMC10097435; DOI: 10.1093/gastro/goad016;

Nelson AD, Fluxá D, Caldera F, Farraye FA, Hashash JG, Kröner PT. Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2023 Jun; 68(6):2597-2603. PMID: 37027107

Patel J, Noureldin M, Fakhouri D, Farraye FA, Kovar-Gough I, Warren B, Waljee AK, Piper MS. Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2023 Jul; 68(7):2921-2935. PMID: 37024741; PMCID: PMC10079156; DOI: 10.1007/s10620-023-07903-7;

Crosby S, Schuh MJ, Becker M, Ivanov M, Caldera F, Farraye FA. New Pneumococcal Vaccines for Prevention of Invasive Pneumococcal Disease in Adult Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Apr 03; 29(4):661-664. PMID: 35830419

Sulbaran M, Chen FK, Farraye FA, Hashash JG. A Clinical Review of Mesenteric Panniculitis. Gastroenterol Hepatol (N Y). 2023 Apr; 19(4):211-218. PMID: 37705847; PMCID: PMC10496345

Bali AS, Hashash JG, Picco MF, Kinnucan JA, Farraye FA. Electronic Health Record Burden Amongst Gastroenterology Providers Associated with Sub-specialty and Training. Am J Gastroenterol. 2023 Mar 20. PMID: 36940436

Bali AS, Hashash JG, Picco MF, Kinnucan JA, Farraye FA. Electronic Health Record Burden Among Gastroenterology Providers Associated With Subspecialty and Training. Am J Gastroenterol. 2023 Jul 01; 118(7):1282-1284. PMID: 36940436

Caldera F, Spaulding AC, Borah B, Moriarty J, Zhu Y, Hayney MS, Farraye FA. Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease. Aliment Pharmacol Ther. 2023 Jun; 57(11):1326-1334. PMID: 36896952

Weaver KN, Zhang X, Dai X, Chen W, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda E, Farraye FA, Craig R, Hernandez C, Boccieri ME, Firestine A, Chun KY, Long MD, Kappelman MD. Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Mar 01; 29(3):483-486. PMID: 35830416; PMCID: PMC9384490; DOI: 10.1093/ibd/izac138;

Kwon JY, Daoud ND, Hashash JG, Picco MF, Farraye FA. Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Feb 01; 29(2):254-259. PMID: 35468183

Kwon JY, Daoud N, Ghoz H, Yataco ML, Farraye FA. Efficacy of a two-dose hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-B) on patients with chronic liver disease: a retrospective study. Transl Gastroenterol Hepatol. 2023; 8:8. PMID: 36704654; PMCID: PMC9813651; DOI: 10.21037/tgh-22-12;

Kalligeros M, Kröner PT, Farraye FA, Desalermos A. Outcomes of endoscopic retrograde cholangiopancreatography in patients with inflammatory bowel disease: a nationwide study. Int J Colorectal Dis. 2023 Jan 24; 38(1):23. PMID: 36692549

Lutz M, Hayney MS, Farraye FA, Caldera F. A Note on Monkeypox for Our Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Jan 05; 29(1):179-180. PMID: 36200852

Patil SA, Bhat S, Limdi JK, Farraye FA, Cross RK. The Sincerest Form of Flattery? Biosimilars in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2022 Dec 01; 28(12):1915-1923. PMID: 35353189

Sullivan KM, Farraye FA, Winthrop KL, Willer DO, Vink P, Tavares-Da-Silva F. Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. Vaccine. 2023 Jan 04; 41(1):36-48. PMID: 36460534

Guerrero Vinsard D, Wakefield D, Karagozian R, Farraye FA. Herpes Zoster in Hospitalized Patients With Inflammatory Bowel Disease: National Analysis of Disease Presentation and Age Distribution. J Clin Gastroenterol. 2023 Nov-Dec 01; 57(10):1038-1044. PMID: 36345559

Schell TL, Knutson KL, Saha S, Wald A, Phan HS, Almasry M, Chun K, Grimes I, Lutz M, Hayney MS, Farraye FA, Caldera F. Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2022 Nov 02; 28(11):1781-1786. PMID: 35396992; PMCID: PMC9047192; DOI: 10.1093/ibd/izac082;

Fluxa D, Roussel B, Hashash JG, Farraye FA. Preventive Care and Health Maintenance in Patients with Inflammatory Bowel Disease. R I Med J (2013). 2022 Nov 01; 105(9):8-12. PMID: 36300957

Hashash JG, Squire J, Francis FF, Binion DG, Cross RK, Farraye FA. An Expert Opinion/Approach: Clinical Presentations, Diagnostic Considerations, and Therapeutic Options for Gastrointestinal Manifestations of Common Variable Immune Deficiency. Am J Gastroenterol. 2022 Nov 01; 117(11):1743-1752. PMID: 36148549

Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda E, Farraye FA, Boccieri ME, Firestine A, Kappelman MD, Long MD. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflamm Bowel Dis. 2022 Oct 03; 28(10):1497-1505. PMID: 34871388; PMCID: PMC8822409; DOI: 10.1093/ibd/izab302;

Nelson AD, Elkins JR, Stocchi L, Farraye FA, Hashash JG. Use and Misuse of Parenteral Nutrition in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2022 Oct 03; 28(10):1592-1602. PMID: 35472221

Hashash JG, Desai A, Kochhar GS, Farraye FA. Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study. Clin Gastroenterol Hepatol. 2023 Mar; 21(3):841-843.e4. PMID: 36152898; PMCID: PMC9492393; DOI: 10.1016/j.cgh.2022.09.011;

Kastl AJ, Weaver KN, Zhang X, Strople JA, Adler J, Dubinsky MC, Bousvaros A, Watkins R, Dai X, Chen W, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda EA, Farraye FA, Chun KY, Zikry M, Fernando M, Bastidas M, Hernandez CG, Craig RG, Boccieri ME, Firestine A, Long MD, Kappelman MD. Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease. Am J Gastroenterol. 2023 Jan 01; 118(1):129-137. PMID: 36114773

Chen B, Collen LV, Mowat C, Isaacs KL, Singh S, Kane SV, Farraye FA, Snapper S, Jneid H, Lavie CJ, Krittanawong C. Inflammatory Bowel Disease and Cardiovascular Diseases. Am J Med. 2022 Dec; 135(12):1453-1460. PMID: 36058305

Desalermos A, Pimienta M, Kalligeros M, Shehadeh F, Diamantopoulos L, Karamanolis G, Caldera F, Farraye FA. Safety of Immunizations for the Adult Patient With Inflammatory Bowel Disease-A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2022 Sep 01; 28(9):1430-1442. PMID: 34849941

Farraye FA. Vaccination Updates for Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2022 Sep; 18(9):538-541. PMID: 36397986; PMCID: PMC9666795

Moktan VP, Daoud ND, Tremaine WJ, Loftus EV, Kane SV, Hochwald AP, Hodge DO, Hashash JG, Faubion SS, Farraye FA. A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease. Crohns Colitis 360. 2022 Jul; 4(3):otac027. PMID: 36045902; PMCID: PMC9421681; DOI: 10.1093/crocol/otac027;

Saade MC, Wehbe H, Mourad FH, Hosni M, Francis FF, Makki M, Binion DG, Tamim H, Farraye FA, Malik T, Hashash JG. Significance of granulomas in the outcomes of Crohn's disease patients. Ann Gastroenterol. 2022; 35(5):503-508. PMID: 36061154; PMCID: PMC9399581; DOI: 10.20524/aog.2022.0730;

Kiran RP, Kochhar GS, Kariv R, Rex DK, Sugita A, Rubin DT, Navaneethan U, Hull TL, Ko HM, Liu X, Kachnic LA, Strong S, Iacucci M, Bemelman W, Fleshner P, Safyan RA, Kotze PG, D'Hoore A, Faiz O, Lo S, Ashburn JH, Spinelli A, Bernstein CN, Kane SV, Cross RK, Schairer J, McCormick JT, Farraye FA, Chang S, Scherl EJ, Schwartz DA, Bruining DH, Philpott J, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sandborn WJ, Silverberg MS, Pardi DS, Church JM, Shen B. Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 Sep; 7(9):871-893. PMID: 35798022

Rangel Paniz G, Lebow J, Sim L, Lacy BE, Farraye FA, Werlang ME. Eating Disorders: Diagnosis and Management Considerations for the IBD Practice. Inflamm Bowel Dis. 2022 Jun 03; 28(6):936-946. PMID: 34096582

Daoud ND, Hashash JG, Picco MF, Farraye FA. Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn's Disease. J Crohns Colitis. 2022 May 10; 16(4):601-605. PMID: 34633435

Hashash JG, Farraye FA. Health Care Maintenance in Patients with Crohn's Disease. Gastroenterol Clin North Am. 2022 Jun; 51(2):441-455. PMID: 35595424

Cohen BL, Fleshner P, Kane SV, Herfarth HH, Palekar N, Farraye FA, Leighton JA, Katz JA, Cohen RD, Gerich ME, Cross RK, Higgins PDR, Tinsley A, Glover S, Siegel CA, Bohl JL, Iskandar H, Ji J, Hu L, Sands BE. Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery. Gastroenterology. 2022 Jul; 163(1):204-221. PMID: 35413359

Fredrick TW, Ramos GP, Braga Neto MB, Kane S, Faubion WA, Loftus EV, Pardi DS, Pasha SF, Farraye FA, Zhang L, Raffals LE. Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis. Crohns Colitis 360. 2022 Apr; 4(2):otac008. PMID: 36777041; PMCID: PMC9802423; DOI: 10.1093/crocol/otac008;

Kappelman MD, Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda EA, Farraye FA, Boccieri ME, Firestine A, Chun KY, Fernando M, Bastidas M, Zikry M, Long MD. Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel Diseases. Am J Gastroenterol. 2022 03 01; 117(3):462-469. PMID: 35029167

Limdi JK, Farraye FA. Real-time use of artificial intelligence at colonoscopy predicts relapse in ulcerative colitis: predicting with "intelligence". Gastrointest Endosc. 2022 04; 95(4):757-759. PMID: 35177257

Kröner PT, Picco MF, Cangemi JR, Hayney MS, Farraye FA, Caldera F. The Burden of Vaccine-preventable Diseases in Patients With Inflammatory Bowel Disease. J Clin Gastroenterol. 2022 Oct 01; 56(9):798-804. PMID: 35152238

Kwon J, Fluxá D, Farraye FA, Kröner PT. Cytomegalovirus-related colitis in patients with inflammatory bowel disease. Int J Colorectal Dis. 2022 Mar; 37(3):685-691. PMID: 35132443

Click B, Merchea A, Colibaseanu DT, Regueiro M, Farraye FA, Stocchi L. Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance. Inflamm Bowel Dis. 2022 02 01; 28(2):289-298. PMID: 33988234

Caldera F, Wald A, Saha S, Smith R, McCrone S, Farraye FA, Hayney MS. Equivalent Cellular and Humoral Immunity to Varicella Zoster Virus in Patients With Inflammatory Bowel Disease and Healthy Older Adults for Whom Immunization Is Recommended. Clin Transl Gastroenterol. 2022 01 19; 13(1):e00446. PMID: 35060934; PMCID: PMC8806369; DOI: 10.14309/ctg.0000000000000446;

Duly K, Farraye FA, Bhat S. COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations. Am J Health Syst Pharm. 2022 01 05; 79(2):63-71. PMID: 34455440; PMCID: PMC8499782; DOI: 10.1093/ajhp/zxab344;

Caldera F, Knutson KL, Saha S, Wald A, Phan HS, Chun K, Grimes I, Lutz M, Hayney MS, Farraye FA. Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls. Am J Gastroenterol. 2022 01 01; 117(1):176-179. PMID: 34797219

Hadi Y, Dulai PS, Kupec J, Mohy-Ud-Din N, Jairath V, Farraye FA, Kochhar GS. Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis. Aliment Pharmacol Ther. 2022 01; 55(2):191-200. PMID: 34904240

Bali AS, Picco MF, Hashash JG, Farraye FA, Kröner PT. Time to Flexible Sigmoidoscopy or Colonoscopy in Patients Admitted With Ulcerative Colitis Has Decreased From 2012 to 2018. Crohns Colitis 360. 2021 Oct; 3(4):otab080. PMID: 36777265; PMCID: PMC9802204; DOI: 10.1093/crocol/otab080;

Kröner PT, Merchea A, Colibaseanu D, Picco MF, Farraye FA, Stocchi L. The use of ileal pouch-anal anastomosis in patients with ulcerative colitis from 2009 to 2018. Colorectal Dis. 2022 Mar; 24(3):308-313. PMID: 34743378

Hashash JG, Picco MF, Farraye FA. Health Maintenance for Adult Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2021; 19(4):583-596. PMID: 34840495; PMCID: PMC8608358; DOI: 10.1007/s11938-021-00364-9;

Daoud ND, Ghoz H, Cannon R, Farraye JA, Picco MF, Kane SV, Kochhar GS, Woodhams EJ, Farraye FA. Oral Contraceptive Pills Are an Effective Method of Preventing Pregnancy in Women With Crohn's Disease. Crohns Colitis 360. 2022 Jan; 4(1):otab078.View Related Profiles.

Woodhams, Elisabeth
Farraye, Francis
Farraye, Jennifer
Cannon, Rachel

PMID: 36777546; PMCID: PMC9802294; DOI: 10.1093/crocol/otab078;

Shen B, Kochhar GS, Rubin DT, Kane SV, Navaneethan U, Bernstein CN, Cross RK, Sugita A, Schairer J, Kiran RP, Fleshner P, McCormick JT, D'Hoore A, Shah SA, Farraye FA, Kariv R, Liu X, Rosh J, Chang S, Scherl E, Schwartz DA, Kotze PG, Bruining DH, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, Picoraro JA, Vermeire S, Sandborn WJ, Silverberg MS, Pardi DS. Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2022 01; 7(1):69-95. PMID: 34774224

Robelin K, Senada P, Ghoz H, Sim L, Lebow J, Picco M, Cangemi J, Farraye FA, Werlang M. Prevalence and Clinician Recognition of Avoidant/Restrictive Food Intake Disorder in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2021 Nov; 17(11):510-514. PMID: 35466311; PMCID: PMC9021160

Cho JM, Loftus EV, Bruining DH, Chedid VG, Farraye FA, Faubion WA, Johnson AM, Kane SV, Kisiel JB, Malik TA, Papadakis KA, Pardi DS, Picco MF, Raffals LE, Schroeder KW, Tremaine WJ, Coelho-Prabhu N. Vulvar Crohn's Disease: Clinical Features and Outcomes. Am J Gastroenterol. 2021 11 01; 116(11):2296-2299. PMID: 34732676

Caldera F, Balzora S, Hayney MS, Farraye FA, Cross RK. Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD. Inflamm Bowel Dis. 2021 Oct 18; 27(10):1703-1705. PMID: 34013958; PMCID: PMC8194672; DOI: 10.1093/ibd/izab114;

Kochhar GS, Mohan BP, Khan SR, Chandan S, Kassab LL, Ponnada S, Desai A, Caldera F, Dulai PS, Farraye FA. Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2021 10 18; 27(10):1610-1619. PMID: 33393585

Hashash JG, Farraye FA. On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease. Crohns Colitis 360. 2021 Oct; 3(4):otab068. PMID: 36777281; PMCID: PMC9802186; DOI: 10.1093/crocol/otab068;

Bhat S, Qazi T, Farraye FA. Managing infliximab infusions after a drug holiday. Am J Health Syst Pharm. 2021 09 07; 78(18):1664-1665. PMID: 34059875

Bhat S, Caldera F, Farraye FA. Standardizing shared vaccination responsibilities among specialists to improve vaccination rates of immunosuppressed patients. Vaccine. 2021 10 01; 39(41):6015-6016. PMID: 34493411; PMCID: PMC8457760; DOI: 10.1016/j.vaccine.2021.08.073;

Shen B, Bortlik M, Bruining DH, Coelho-Prabhu N, El-Hachem S, Farraye FA, Iacucci M, Kobayashi T, Kochhar GS, Kotze PG, Lama YG, Levy AN, Liu X, Mao R, Navaneethan U, Schwartz DA, Shergill A, Sood A, Suárez BG. Endoscopic evaluation after surgery in inflammatory bowel disease - Authors' reply. Lancet Gastroenterol Hepatol. 2021 09; 6(9):691-692. PMID: 34391522

Nigam GB, Patel RN, Bressler B, Hayee B, Iacucci M, Farraye FA, Limdi JK. Clinician perspectives on the use of artificial intelligence in inflammatory bowel disease. Gastrointest Endosc. 2021 09; 94(3):662-663. PMID: 34412829

Shen B, Kochhar GS, Kariv R, Liu X, Navaneethan U, Rubin DT, Cross RK, Sugita A, D'Hoore A, Schairer J, Farraye FA, Kiran RP, Fleshner P, Rosh J, Shah SA, Chang S, Scherl E, Pardi DS, Schwartz DA, Kotze PG, Bruining DH, Kane SV, Philpott J, Abraham B, Segal J, Sedano R, Kayal M, Bentley-Hibbert S, Tarabar D, El-Hachem S, Sehgal P, McCormick JT, Picoraro JA, Silverberg MS, Bernstein CN, Sandborn WJ, Vermeire S. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol Hepatol. 2021 10; 6(10):826-849. PMID: 34416186

Hashash JG, Francis FF, Farraye FA. Diagnosis and Management of Immune Checkpoint Inhibitor Colitis. Gastroenterol Hepatol (N Y). 2021 Aug; 17(8):358-366. PMID: 34602898; PMCID: PMC8475264

Squire JD, Gonzalez-Estrada A, Caldera F, Farraye FA. COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies. Inflamm Bowel Dis. 2021 07 27; 27(8):1358-1360. PMID: 33999204; PMCID: PMC8194689; DOI: 10.1093/ibd/izab094;

Bhat S, Caldera F, Farraye FA. Barriers to Administering Vaccines in Inflammatory Bowel Disease Centers. Inflamm Bowel Dis. 2021 07 27; 27(8):1356-1357. PMID: 33704465; PMCID: PMC7989212; DOI: 10.1093/ibd/izab055;

Moktan VP, Koop AH, Olson MT, Lewis MD, Gomez V, Farraye FA. An Unusual Cause of Large Bowel Obstruction in a Patient With Ulcerative Colitis. ACG Case Rep J. 2021 Jul; 8(7):e00638. PMID: 34307716; PMCID: PMC8294864; DOI: 10.14309/crj.0000000000000638;

Bhat S, Limdi JK, Cross RK, Farraye FA. Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease. Dig Dis Sci. 2021 08; 66(8):2513-2532. PMID: 34176024

Farraye FA, Qazi T, Kotze PG, Moore GT, Mundayat R, Lawendy N, Sharma PP, Judd DT. The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme. Aliment Pharmacol Ther. 2021 08; 54(4):429-440. PMID: 34165201; PMCID: PMC8362064; DOI: 10.1111/apt.16439;

Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, Albuquerque A, Allocca M, Esteve M, Farraye FA, Gordon H, Karmiris K, Kopylov U, Kirchgesner J, MacMahon E, Magro F, Maaser C, de Ridder L, Taxonera C, Toruner M, Tremblay L, Scharl M, Viget N, Zabana Y, Vavricka S. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis. 2021 Jun 22; 15(6):879-913. PMID: 33730753

Kochhar GS, Desai A, Caldera DO F, El Hachem S, Aoun E, Sandhu D, Mohan BP, Dulai PS, Farraye FA. Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease. Vaccine. 2021 07 05; 39(30):4199-4202. PMID: 34140170

Zaver HB, Ghoz H, Azar A, Alexander LF, Toskich B, Edgar MA, Krishna M, Colibaseanu DT, Brahmbhatt B, Farraye FA. Inferior Mesenteric Arteriovenous Malformation Masquerading as Ulcerative Colitis. Am J Gastroenterol. 2021 06 01; 116(6):1114. PMID: 33177344

Crosby S, Schuh MJ, Farraye FA. Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab. J Crohns Colitis. 2021 05 04; 15(5):871. PMID: 33016326

Shen B, Kochhar GS, Navaneethan U, Cross RK, Farraye FA, Iacucci M, Schwartz DA, Gonzalez-Lama Y, Schairer J, Kiran RP, Kotze PG, Kobayashi T, Bortlik M, Liu X, Levy AN, González Suárez B, Tang SJ, Coelho-Prabhu N, Lukas M, Bruining DH, El-Hachem S, Charles RJ, Chen Y, Sood A, Mao R, Loras C, Dulai PS, Picoraro JA, Chiorean M, Lukas M, Shergill A, Silverberg MS, Sandborn WJ, Bernstein CN. Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group. Lancet Gastroenterol Hepatol. 2021 06; 6(6):482-497. PMID: 33872568

Limdi JK, Farraye FA. The Great Debate With IBD Biosimilars: Pro: Biosimilars Should Be Routinely Used as a First Line Biologic and May Be Switched From Reference Biologics. Crohns Colitis 360. 2021 Jul; 3(3):otab015. PMID: 36776664; PMCID: PMC9802304; DOI: 10.1093/crocol/otab015;

Chugh R, Kröner PT, Farraye FA, Ginsburg PM. Small-Bowel Lymphoma Mimicking Crohn Disease: A Case Series. Inflamm Bowel Dis. 2021 04 15; 27(5):e61-e62. PMID: 33501981

Kröner PT, Lee A, Farraye FA. Respiratory Tract Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021 03 15; 27(4):563-574. PMID: 32448912

Moktan V, Jonica E, Li Z, Hata DJ, Farraye FA. C. difficile and the Patient with Inflammatory Bowel Disease: A Testing Dilemma. Dig Dis Sci. 2021 03; 66(3):921-922. PMID: 32803461

Limdi JK, Farraye FA. Automated endoscopic assessment in ulcerative colitis: the next frontier. Gastrointest Endosc. 2021 03; 93(3):737-739. PMID: 33583524

Montenegro ML, Corral JE, Lukens FJ, Ji B, Kröner PT, Farraye FA, Bi Y. Pancreatic Disorders in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2022 02; 67(2):423-436. PMID: 33625614

Qazi T, Smith A, Alexander M, Hammer D, Wu T, Auerbach S, Noronha A, Wasan S, Jones E, Weinberg J, Farraye FA. Disparities in Objective Sleep Quality as Assessed Through Wrist Actigraphy in Minority Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021 02 16; 27(3):371-378.View Related Profiles.

Farraye, Francis
Weinberg, Janice
Wasan, Sharmeel

PMID: 32448906

Rolak S, Hayney MS, Farraye FA, Temte JL, Caldera F. What Gastroenterologists Should Know About COVID-19 Vaccines. Clin Gastroenterol Hepatol. 2021 04; 19(4):657-661. PMID: 33548200; PMCID: PMC7857702; DOI: 10.1016/j.cgh.2021.01.001;

Bhat S, Farraye FA, Hayney MS, Caldera F. How to Implement a Successful Vaccination Program in Outpatient Gastroenterology Practices: A Focus on Patients With Inflammatory Bowel Disease and Chronic Liver Disease. Gastroenterology. 2023 Jun; 164(7):1047-1051. PMID: 33460608

Caldera F, Ley D, Hayney MS, Farraye FA. Erratum to: Optimizing Immunization Strategies in Patients with IBD. Inflamm Bowel Dis. 2021 01 01; 27(1):e9. PMID: 33027525

Crosby S, Schuh MJ, Caldera F, Farraye FA. Vaccination of Patients With Inflammatory Bowel Disease During the COVID-19 Pandemic. Gastroenterol Hepatol (N Y). 2021 Jan; 17(1):18-30. PMID: 34035759; PMCID: PMC8132679

Caldera F, Ley D, Hayney MS, Farraye FA. Optimizing Immunization Strategies in Patients with IBD. Inflamm Bowel Dis. 2021 01 01; 27(1):123-133. PMID: 32232388

Corral JE, Kwon JY, Caldera F, Pungpapong S, Spaulding AC, Borah BJ, Moriarty JP, Farraye FA. Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients With Inflammatory Bowel Disease. Crohns Colitis 360. 2021 Jan; 3(1):otaa090. PMID: 36777070; PMCID: PMC9802290; DOI: 10.1093/crocol/otaa090;

Harrington JE, Hamilton RE, Ganley-Leal L, Farraye FA, Wasan SK. The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab. Crohns Colitis 360. 2020 Oct; 2(4):otaa082.View Related Profiles.

Farraye, Francis
Harrington, Jill
Wasan, Sharmeel

PMID: 36777751; PMCID: PMC9802260; DOI: 10.1093/crocol/otaa082;

Green ME, Brahmbhatt B, Baumgarten D, Krishna M, Stocchi L, Farraye FA. Meckel's Diverticulum Masquerading as Crohn Disease. Inflamm Bowel Dis. 2020 10 23; 26(11):e150-e151. PMID: 32692353

Smith R, Hubers J, Farraye FA, Sampene E, Hayney MS, Caldera F. Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2021 09; 66(9):2935-2941. PMID: 32995995; PMCID: PMC7524037; DOI: 10.1007/s10620-020-06631-6;

Lutz M, Hayney MS, Farraye FA, Caldera F. Reducing the Risk of Vaccine Preventable Diseases During the COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2020 12; 18(13):2868-2872. PMID: 32979321; PMCID: PMC7513818; DOI: 10.1016/j.cgh.2020.08.011;

Paulsen MR, Patel NR, Sulis C, Farraye FA, Bhat S. Human Papillomavirus, Herpes Zoster, and Hepatitis B Vaccinations in Immunocompromised Patients: An Update for Pharmacists. J Pharm Pract. 2021 Dec; 34(6):943-951. PMID: 32938309

Caldera F, Hayney MS, Farraye FA. Vaccination in Patients With Inflammatory Bowel Disease. Am J Gastroenterol. 2020 09; 115(9):1356-1361. PMID: 32744811

Bhat S, Farraye FA, Moss AC. Impact of Clinical Pharmacists in Inflammatory Bowel Disease Centers During the COVID-19 Pandemic. Am J Gastroenterol. 2020 09; 115(9):1532-1533.View Related Profiles.

Moss, Alan
Farraye, Francis

PMID: 32694291; PMCID: PMC7396223; DOI: 10.14309/ajg.0000000000000787;

Guo L, Rohde J, Farraye FA. Stigma and Disclosure in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 06 18; 26(7):1010-1016. PMID: 32556190

Grossberg LB, Farraye FA, Papamichael K, Cheifetz AS, Feuerstein JD. A Survey Study of Gastroenterologists' Views on Dysplasia Surveillance and Chromoendoscopy in IBD. Inflamm Bowel Dis. 2020 06 18; 26(7):e59-e61. PMID: 32304571

Chen Y, Yu Q, Farraye FA, Kochhar GS, Bernstein CN, Navaneethan U, Wu K, Zhong J, Schwartz DA, Wu H, Zheng JJ, Iacucci M, Kiran RP, Shen B. Patterns of endoscopy during COVID-19 pandemic: a global survey of interventional inflammatory bowel disease practice. Intest Res. 2021 Jul; 19(3):332-340. PMID: 32475088; PMCID: PMC8322031; DOI: 10.5217/ir.2020.00037;

Bhat S, Farraye FA, Moss A. Roles of Clinical Pharmacists in Caring for Patients With Inflammatory Bowel Disease During COVID-19. Gastroenterology. 2021 04; 160(5):1880.View Related Profiles.

Moss, Alan
Farraye, Francis

PMID: 32425232; PMCID: PMC7233231; DOI: 10.1053/j.gastro.2020.05.044;

Chen Y, Hu S, Wu H, Farraye FA, Bernstein CN, Zheng JJ, Kiran RP, Shen B. Patterns of care for inflammatory bowel disease in China during the COVID-19 pandemic. Lancet Gastroenterol Hepatol. 2020 07; 5(7):632-634. PMID: 32411921; PMCID: PMC7220174; DOI: 10.1016/S2468-1253(20)30131-X;

Corral JE, Hoogenboom SA, Kröner PT, Vazquez-Roque MI, Picco MF, Farraye FA, Wallace MB. COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis. Gastrointest Endosc. 2020 09; 92(3):524-534.e6. PMID: 32360302; PMCID: PMC7187877; DOI: 10.1016/j.gie.2020.04.049;

Bhat S, Altajar S, Shankar D, Zahorian T, Robert R, Qazi T, Shah B, Farraye FA. Process and Clinical Outcomes of a Biosimilar Adoption Program with Infliximab-Dyyb. J Manag Care Spec Pharm. 2020 Apr; 26(4):410-416.View Related Profiles.

Shankar, Divya Anjana
Farraye, Francis

PMID: 32223602; PMCID: PMC10390955; DOI: 10.18553/jmcp.2020.26.4.410;

Ikezu T, Koro L, Wolozin B, Farraye FA, Strongosky AJ, Wszolek ZK. Crohn's and Parkinson's Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14+ Blood Monocytes Ex Vivo. J Neuroimmune Pharmacol. 2020 12; 15(4):794-800.View Related Profiles.

Wolozin, Benjamin
Farraye, Francis
Ikezu, Tsuneya

PMID: 32180132; PMCID: PMC7718203; DOI: 10.1007/s11481-020-09909-8;

Shen B, Kochhar G, Navaneethan U, Farraye FA, Schwartz DA, Iacucci M, Bernstein CN, Dryden G, Cross R, Bruining DH, Kobayashi T, Lukas M, Shergill A, Bortlik M, Lan N, Lukas M, Tang SJ, Kotze PG, Kiran RP, Dulai PS, El-Hachem S, Coelho-Prabhu N, Thakkar S, Mao R, Chen G, Zhang S, Suárez BG, Lama YG, Silverberg MS, Sandborn WJ. Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease Group. Lancet Gastroenterol Hepatol. 2020 04; 5(4):393-405. PMID: 31954438

Satyam VR, Li PH, Reich J, Qazi T, Noronha A, Wasan SK, Farraye FA. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2020 10; 65(10):2986-2991.View Related Profiles.

Noronha, Ansu
Farraye, Francis
Wasan, Sharmeel
Satyam, Venkata

PMID: 31897892

Qazi T, Farraye FA. Sleep Disturbances in the Elderly Patient with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2019 Dec; 17(4):470-491. PMID: 31776805

Limdi JK, Picco M, Farraye FA. A review of endoscopic scoring systems and their importance in a treat-to-target approach in inflammatory bowel disease (with videos). Gastrointest Endosc. 2020 04; 91(4):733-745. PMID: 31786161

Picco MF, Farraye FA. Targeting Mucosal Healing in Crohn's Disease. Gastroenterol Hepatol (N Y). 2019 Oct; 15(10):529-538. PMID: 31802977; PMCID: PMC6883736

Limdi JK, Farraye J, Cannon R, Woodhams E, Farraye FA. Contraception, Venous Thromboembolism, and Inflammatory Bowel Disease: What Clinicians (and Patients) Should Know. Inflamm Bowel Dis. 2019 09 18; 25(10):1603-1612.View Related Profiles.

Woodhams, Elisabeth
Farraye, Francis
Farraye, Jennifer
Cannon, Rachel

PMID: 30877770

Bhat S, Zahorian T, Robert R, Farraye FA. Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process. Inflamm Bowel Dis. 2019 09 18; 25(10):1621-1628. PMID: 30753551

Kröner PT, Mody K, Farraye FA. Immune checkpoint inhibitor-related luminal GI adverse events. Gastrointest Endosc. 2019 12; 90(6):881-892. PMID: 31526811

Caldera F, Farraye FA, Rosh JR, Hayney MS. Prudence Using Serology to Determine Vaccine-Induced Immunity to Measles and Varicella in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019 08 20; 25(9):e113. PMID: 31165856

Feuerstein JD, Moss AC, Farraye FA. Ulcerative Colitis. Mayo Clin Proc. 2019 07; 94(7):1357-1373.View Related Profiles.

Moss, Alan
Farraye, Francis

PMID: 31272578

Boden EK, Canavan JB, Moran CJ, McCann K, Dunn WA, Farraye FA, Ananthakrishnan AN, Yajnik V, Gandhi R, Nguyen DD, Bhan AK, Weiner HL, Korzenik JR, Snapper SB. Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative Colitis. Crohns Colitis 360. 2019 Jul; 1(2):otz009. PMID: 31423487; PMCID: PMC6690423; DOI: 10.1093/crocol/otz009;

Qazi T, Farraye FA. Sleep and Inflammatory Bowel Disease: An Important Bi-Directional Relationship. Inflamm Bowel Dis. 2019 04 11; 25(5):843-852. PMID: 30388243

Chudy-Onwugaje KO, Christian KE, Farraye FA, Cross RK. A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD. Inflamm Bowel Dis. 2019 04 11; 25(5):820-830. PMID: 30445504; PMCID: PMC6468492; DOI: 10.1093/ibd/izy327;

Pratt PK, Nunes D, Long MT, Farraye FA. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2019 07; 64(7):2031-2038.View Related Profiles.

Nunes, David
Farraye, Francis
Long, Michelle

PMID: 30945037; PMCID: PMC6764090; DOI: 10.1007/s10620-019-05595-6;

Reich J, Guo L, Groshek J, Weinberg J, Chen W, Martin C, Long MD, Farraye FA. Social Media Use and Preferences in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019 02 21; 25(3):587-591.View Related Profiles.

Farraye, Francis
Weinberg, Janice

PMID: 30203036

Apte M, Reich J, Zahorian T, Farraye FA. Improving Vaccination Rates for IBD Patients Through the Use of Local Pharmacies. Inflamm Bowel Dis. 2019 02 21; 25(3):e19.View Related Profiles.

Farraye, Francis
Apte, Manisha

PMID: 29893866

Zullow S, Farraye FA. Updates on vaccinating the inflammatory bowel disease patient. Expert Rev Gastroenterol Hepatol. 2019 Mar; 13(3):229-239. PMID: 30791761

Navaneethan U, Farraye FA. Expanding the horizons in interventional inflammatory bowel disease: endoscopic sinusotomy for the treatment of chronic pouch anastomotic sinus. Gastrointest Endosc. 2019 01; 89(1):157-158. PMID: 30567674

Tormey LK, Reich J, Chen YS, Singh A, Lipkin-Moore Z, Yu A, Weinberg J, Farraye FA, Paasche-Orlow MK. Limited Health Literacy Is Associated With Worse Patient-Reported Outcomes in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2019 01 01; 25(1):204-212.View Related Profiles.

Farraye, Francis
Weinberg, Janice
Paasche-Orlow, Michael

PMID: 29992302

Coukos J, Farraye FA. Update on Vaccinating the Patient With Inflammatory Bowel Disease. Curr Treat Options Gastroenterol. 2018 Dec; 16(4):548-560. PMID: 30293209

Shen B, Kochhar G, Navaneethan U, Liu X, Farraye FA, Gonzalez-Lama Y, Bruining D, Pardi DS, Lukas M, Bortlik M, Wu K, Sood A, Schwartz DA, Sandborn WJ. Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group. Gastrointest Endosc. 2019 02; 89(2):215-237. PMID: 30365985

Caldera F, Farraye FA, Kane S. The Who and Why of Herpes Zoster Vaccination in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2018 12; 16(12):1872-1875. PMID: 30153518

Szeto W, van der Bent A, Petty CR, Reich J, Farraye F, Fishman LN. Use of Social Media for Health-Related Tasks by Adolescents With Inflammatory Bowel Disease: A Step in the Pathway of Transition. Inflamm Bowel Dis. 2018 05 18; 24(6):1114-1122. PMID: 29788360; PMCID: PMC6093193; DOI: 10.1093/ibd/izy021;

Limdi JK, Farraye FA. An Update on Surveillance in Ulcerative Colitis. Curr Gastroenterol Rep. 2018 Mar 07; 20(2):7. PMID: 29516293

Naidu H, Szeto W, Kissin E, Farraye FA. MAGIC Syndrome in a Patient With Crohn's Disease. Inflamm Bowel Dis. 2018 02 15; 24(3):664-665.View Related Profiles.

Kissin, Eugene
Farraye, Francis

PMID: 29462377

Pratt PK, David N, Weber HC, Little FF, Kourkoumpetis T, Patts GJ, Weinberg J, Farraye FA. Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy. Inflamm Bowel Dis. 2018 01 18; 24(2):380-386.View Related Profiles.

Farraye, Francis
Little, Frederic
Weber, H.
Weinberg, Janice
Pratt, Perry

PMID: 29361083

Limdi J, Farraye FA. Inflammatory Bowel Disease: Diagnosis and Therapeutics 3rd edition. Gastroenterology. 2018; 155(2). View Publication
Satyam VR, Zullow S, Noronha A, Farraye FA. Mo1875 - Efficacy of Ustekinumab in Patients with Refractory Perianal Crohn's Disease in a Tertiary Care IBD Center. Gastroenterology. 2018; 154(6):S-834. View Publication
Limdi J, Farraye FA. Treatment of Inflammatory Bowel Disease with Biologics. Anti-integrin Agents in IBD: Efficacy and Risk of Complications. 2018; 283-301. View Publication

Rohde JA, Wang Y, Cutino CM, Dickson BK, Bernal MC, Bronda S, Liu A, Priyadarshini SI, Guo L, Reich JS, Farraye FA. Impact of Disease Disclosure on Stigma: An Experimental Investigation of College Students' Reactions to Inflammatory Bowel Disease. J Health Commun. 2018; 23(1):91-97. PMID: 29283816

Groshek J, Basil M, Guo L, Parker Ward S, Farraye FA, Reich J. Media Consumption and Creation in Attitudes Toward and Knowledge of Inflammatory Bowel Disease: Web-Based Survey. J Med Internet Res. 2017 Dec 08; 19(12):e403. PMID: 29222081; PMCID: PMC5741823; DOI: 10.2196/jmir.7624;

Saxena AP, Limdi JK, Farraye FA. Zeroing in on endoscopic and histologic mucosal healing to reduce the risk of colorectal neoplasia in inflammatory bowel disease. Gastrointest Endosc. 2017 12; 86(6):1012-1014.View Related Profiles.

Saxena, Akriti
Farraye, Francis

PMID: 29146080

Reich J, Wasan SK, Farraye FA. Vaccination and Health Maintenance Issues to Consider in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017 Dec; 13(12):717-724.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 29339947; PMCID: PMC5763557

Fine S, Nee J, Thakuria P, Duff B, Farraye FA, Shah SA. Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease. Dig Dis Sci. 2017 Dec; 62(12):3269-3279. PMID: 29064013

Caldera F, Wasan SK, Farraye FA, Hayney MS. Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 10; 23(10):E50-E51.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 28906295

Iskandar H, Greer JB, Krasinskas AM, Tinsley AT, Koltun WA, Siegel CA, Levy LC, Herfarth HH, Farraye FA, Binion DG, Rosh JR, Keljo DJ, Isaacs KL, Regueiro MD. IBD LIVE Series-Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa. Inflamm Bowel Dis. 2017 10; 23(10):1667-1677. PMID: 28906288

Farraye, Francis
Wasan, Sharmeel

PMID: 28922256

Kaltenbach TR, Soetikno RM, DeVivo R, Laine LA, Barkun A, McQuaid KR. Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching. Gastrointest Endosc. 2017 Dec; 86(6):1107-1117.e1. PMID: 28818507; DOI: 10.1016/j.gie.2017.07.045;

Farraye FA. Vaccination of Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2017 Jul; 13(7):431-434. PMID: 28867973; PMCID: PMC5572975

Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure. J Clin Gastroenterol. 2017 Jul; 51(6):508-511. PMID: 27433811; PMCID: PMC5243925; DOI: 10.1097/MCG.0000000000000604;

Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017 Jul; 112(7):1208. PMID: 28534523

Zullow S, Fazelat A, Farraye FA. Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC. Inflamm Bowel Dis. 2017 05; 23(5):E19.View Related Profiles.

Farraye, Francis
Zullow, Samantha

PMID: 28328626; DOI: 10.1097/MIB.0000000000001091;

Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease. Am J Gastroenterol. 2017 Feb; 112(2):241-258. PMID: 28071656; DOI: 10.1038/ajg.2016.537;

Singh V, Groshek J, Guo L, Basil M, Farraye FA, Reich J. An Analysis of Social Media Use Surrounding the Approval of Ustekinumab (Stelara) for the Treatment of Crohn's Disease. Gastroenterology. 2017; 152(5):S801. View Publication
Oppong Twene P, Farraye FA, Dhere T, Body CB, Patzer R, Gardner D, Ward A, Iskandar H. A Behavioral Intervention Increases Medication Adherence in Inflammatory Bowel Disease (IBD) Patients: A Prospective Study. Gastroenterology. 2017; 152(5):S123. View Publication
Hamilton R, Singh V, Connor JH, Schneider T, Farraye FA, Ganley-Leal LM. Systemic TNF-a Reduction by Blocking IgE-Mediated Cellular Activation. Gastroenterology. 2017; 152(5):S760-S761. View Publication
Jonica ER, Hughes M, Soni K, Jones EA, Weinberg J, Miller NS, Sulis CA, Farraye FA. Role of Cycle Times of Polymerase Chain Reaction Testing for Clostridium Difficile as a Predictor of Clinical Outcomes in Patients with Inflammatory Bowel Disease. Gastroenterology. 2017; 152(5):S611. View Publication
Limdi J, Farraye FA. Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Incidence of Cancer and Screening in Inflammatory Bowel Disease. 2017; 639-652. View Publication

Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg G, Huang C, Tran DD, Glaser JP, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla AP, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. Am J Gastroenterol. 2017 Mar; 112(3):447-457.View Related Profiles.

Apovian, Caroline
Huang, Christopher
Farraye, Francis

PMID: 27922026; PMCID: PMC5350543; DOI: 10.1038/ajg.2016.500;

Rajan D, Greer JB, Regueiro MD, Baidoo L, Binion DG, Herfarth HH, Siegel CA, Hartman DJ, Farraye FA, Koutroubakis IE, Brand MH, Williams ED, Goyal A, Cross RK. IBD LIVE Case Series-Case 6: Persistent Skin Lesions in a Patient with Crohn's Disease: You Hear Hoof Beats and Discover a Zebra. Inflamm Bowel Dis. 2016 Nov; 22(11):2754-2764. PMID: 27846035

Zullow S, Wasan SK, Shah B, Farraye FA. Reply. Inflamm Bowel Dis. 2016 11; 22(11):E44-E45.View Related Profiles.

Farraye, Francis
Zullow, Samantha
Wasan, Sharmeel

PMID: 27755275

Rajan D, Greer JB, Regueiro MD, Baidoo L, Binion DG, Herfarth HH, Siegel CA, Hartman DJ, Farraye FA, Koutroubakis IE, Brand MH, Williams ED, Goyal A, Cross RK. IBD LIVE Case Series-Case 6. Inflamm Bowel Dis. 2016 11; 22(11):2754-2764. PMID: 27755273

Reich J, Guo L, Hall J, Tran A, Weinberg J, Groshek J, Rowell TE, DiPalma JA, Farraye FA. A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 11; 22(11):2678-2687.View Related Profiles.

Tran, Ashley
Farraye, Francis
Weinberg, Janice

PMID: 27755269

Abdat R, Markova A, Farraye FA, Lichtman MK. Ustekinumab for treatment of cutaneous Crohn's disease. Dermatol Online J. 2016 Oct 15; 22(10).View Related Profiles.

Farraye, Francis
Lichtman, Michael

PMID: 28329588

Reich J, Wasan S, Farraye FA. Vaccinating Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016 Sep; 12(9):540-546.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 27917091; PMCID: PMC5114511

Kisiel JB, Konijeti GG, Piscitello AJ, Chandra T, Goss TF, Ahlquist DA, Farraye FA, Ananthakrishnan AN. Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2016 Dec; 14(12):1778-1787.e8. PMID: 27464589; PMCID: PMC5108686; DOI: 10.1016/j.cgh.2016.07.018;

Anastassopoulos K, Farraye FA, Knight T, Colman S, Cleveland MV, Pelham RW. A Comparative Study of Treatment-Emergent Adverse Events Following Use of Common Bowel Preparations Among a Colonoscopy Screening Population: Results from a Post-Marketing Observational Study. Dig Dis Sci. 2016 Oct; 61(10):2993-3006. PMID: 27278957; PMCID: PMC5020112; DOI: 10.1007/s10620-016-4214-2;

Wasan SK, Zullow S, Berg A, Cheifetz AS, Ganley-Leal L, Farraye FA. Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression. Inflamm Bowel Dis. 2016 Jun; 22(6):1391-6.View Related Profiles.

Farraye, Francis
Zullow, Samantha
Wasan, Sharmeel

PMID: 27057679; DOI: 10.1097/MIB.0000000000000743;

Gulati A, Clarke K, Greer JB, Binion DG, Brand MH, Farraye FA, Cross RK, Baidoo L, Schraut WH, Hartman DJ, Regueiro MD. IBD LIVE Case Series-Case 4: Worms in IBD: Friend or Foe. Inflamm Bowel Dis. 2016 06; 22(6):1462-72. PMID: 27182771; DOI: 10.1097/MIB.0000000000000770;

Guo L, Reich J, Groshek J, Farraye FA. Social Media Use in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 May; 22(5):1231-8. PMID: 26894839; DOI: 10.1097/MIB.0000000000000713;

Reich JS, Farraye FA, Wasan SK. Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New? Dig Dis Sci. 2016 Aug; 61(8):2205-16.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 27061291; DOI: 10.1007/s10620-016-4146-x;

Hughes M, Qazi T, Berg A, Weinberg J, Chen X, Kelly CP, Farraye FA. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2016 Apr; 22(4):853-61.View Related Profiles.

Farraye, Francis
Weinberg, Janice

PMID: 26954708; PMCID: PMC4792680; DOI: 10.1097/MIB.0000000000000696;

Tormey LK, Farraye FA, Paasche-Orlow MK. Understanding Health Literacy and its Impact on Delivering Care to Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016 Mar; 22(3):745-51.View Related Profiles.

Farraye, Francis
Paasche-Orlow, Michael

PMID: 26595554; DOI: 10.1097/MIB.0000000000000622;

Pratt PK, Kourkoumpetis T, Weber HC, Farraye FA. 994 Antibody Response to Three-Dose Hepatitis B Vaccine Is Reduced in Inflammatory Bowel Disease Patients on Anti-TNF Medications. Gastroenterology. 2016; 150(4):S204. View Publication
Tormey L, Reich J, Chen S, Lipkin-Moore Z, Yu A, Weinberg J, Farraye FA, Paasche-Orlow M. Mo1855 Inadequate Health Literacy Linked to Poor Knowledge of Key Concepts in Inflammatory Bowel Disease. Gastroenterology. 2016; 150(4):S796. View Publication
Guo L, Groshek J, Farraye FA, Reich J . Tu1118 The 2015 Annual American College of Gastroenterology Meeting: Insights From a Twitter Analysis. Gastroenterology. 2016; 150(4):S848. View Publication
Regueiro M, Greer JB, Cross R, Williams E, Tinsley A, Herfarth H, Siegel CA, Brand M, Goyal A, Keljo DJ, Binon DG, Farraye FA, Iskandar H, Shah SA, Hashash JG, Schraut WH, Hartman DJ, Davis PL, Szigethy E, Watson AR. Mo1862 A Virtual Case Management Program for a New Era of Healthcare: The Inflammatory Bowel Disease Live Inter-Institutional and Interdisciplinary Videoconference Education (IBD LIVE) Series Improves Quality of Care. Gastroenterology. 2016; 150(4):S798. View Publication
Shergill AK, Farraye FA. Endoscopic Evaluation for Colon Cancer and Dysplasia in Patients with Inflammatory Bowel Disease. Techniques in Gastrointestinal Endoscopy. 2016; 18(3). View Publication
Zullow S, Wasan SK, Shah B, Farraye FA. Reply: Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2016; 22(11):E44-E45. View Publication
Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amarro A, Apovian CM, Fullum T, Zarrinpar A, Jensen MD, Stein AC, Edmundowicz S, Kahaleh M, Ryou M, Bohning JM, Ginsberg GG, Huang C, Tran DD, Martin JA, Jaffe DL, Farraye FA, Ho SB, Kumar N, Harakal D, Young M, Thomas CE, Shukla A, Ryan MB, Haas M, Goldsmith H, McCrea J, Aronne LJ. 381 The AspireAssist Is an Effective Tool in the Treatment of Class II and Class III Obesity: Results of a One-Year Clinical Trial. Gastroenterology. 2016; 150(4):S86. View Publication
Desalermos AP, Farraye FA, Miller H. Total Parenteral Nutrition and Inflammatory Bowel Disease: Indication, Long term Outcomes, and Complications. Vitamin D and Inflammatory Bowel Disease. 2016; 31-51. View Publication
Tormey L, Reich J, Chen S, Lipkin-Moore Z, Yu A, Weinberg J, Farraye FA, Paasche-Orlow M. Sa1905 The Impact of Medication Self-Efficacy and Health Literacy on Patient-Reported Outcomes in Inflammatory Bowel Disease. Gastroenterology. 2016; 150(4):S398-S399. View Publication

Huynh L, Yermakov S, Davis M, Campbell R, Cleveland M, Farraye FA, Yenikomshian M. Cost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS). J Med Econ. 2016; 19(4):356-63. PMID: 26610148; DOI: 10.3111/13696998.2015.1125907;

Naidu H, Farraye FA, Noronha A. Elective colectomy for severe ulcerative colitis may reduce mortality more than medical therapy. Evid Based Med. 2016 Feb; 21(1):29.View Related Profiles.

Noronha, Ansu
Farraye, Francis

PMID: 26642847; DOI: 10.1136/ebmed-2015-110311;

Iskandar HN, Dhere T, Farraye FA. Ulcerative Colitis: Update on Medical Management. Curr Gastroenterol Rep. 2015 Nov; 17(11):44. PMID: 26386686; DOI: 10.1007/s11894-015-0466-9;

Qazi T, Shah B, El-Dib M, Farraye FA. The Tolerability and Efficacy of Rapid Infliximab Infusions in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2016 Feb; 61(2):589-96. PMID: 26441281; DOI: 10.1007/s10620-015-3893-4;

Okafor PN, Farraye FA, Okafor AT, Erim DO. Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease. Dig Dis Sci. 2015 Dec; 60(12):3743-55. PMID: 26177704; DOI: 10.1007/s10620-015-3796-4;

Shen J, Gibson JA, Schulte S, Khurana H, Farraye FA, Levine J, Burakoff R, Cerda S, Qazi T, Hamilton M, Srivastava A, Odze RD. Clinical, pathologic, and outcome study of hyperplastic and sessile serrated polyps in inflammatory bowel disease. Hum Pathol. 2015 Oct; 46(10):1548-56.View Related Profiles.

Farraye, Francis
Cerda, Sandra

PMID: 26297256; DOI: 10.1016/j.humpath.2015.06.019;

Reich JS, Miller HL, Wasan SK, Noronha A, Ardagna E, Sullivan K, Jacobson B, Farraye FA. Influenza and Pneumococcal Vaccination Rates in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2015 Jun; 11(6):396-401.View Related Profiles.

Noronha, Ansu
Jacobson, Brian
Farraye, Francis
Sullivan, Kathleen
Wasan, Sharmeel

PMID: 27118933; PMCID: PMC4843033

Stallwood C, Shergill K, Wu J, Farraye FA, Miller HL. Erratum. Scand J Gastroenterol. 2015 Jul; 50(7):932. PMID: 25700202; DOI: 10.3109/00365521.2015.1017333;

Stallwood C, Shergill K, Wu J, Farraye FA, Miller HL. Manifestations of inflammatory bowel disease in patients of Haitian and Cape Verdean descent. Scand J Gastroenterol. 2015 Jul; 50(7):832-40.View Related Profiles.

Farraye, Francis
Miller, Hannah

PMID: 25652938; DOI: 10.3109/00365521.2015.1008034;

Kalman RS, Hartshorn K, Farraye FA. Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD. Inflamm Bowel Dis. 2015 Feb; 21(2):428-35.View Related Profiles.

Farraye, Francis
Hartshorn, Kevan

PMID: 25251059; DOI: 10.1097/MIB.0000000000000211;

Tormey L, Reich J, Singh A, Chen Y, Weinberg J, Farraye FA, Paasche-Orlow M. Sa1205 The Impact of Health Literacy on Patient-Reported Outcomes in Inflammatory Bowel Disease. Gastroenterology. 2015; 148(4):S256-S257. View Publication
Clermont MP, Mandalia AB, Gardner D, Farraye FA, Iskandar H. Tu1241 Does Race Play a Role in Medication Adherence in Inflammatory Bowel Disease Patients?. Gastroenterology. 2015; 148(4):S833. View Publication
Sands BE, Shafran I, Farraye FA, Cheifetz AS, Abhyankar B, Sankoh S, Smyth MD. Sa1272 Efficacy and Safety of Retreatment With Vedolizumab in Patients With Ulcerative Colitis. Gastroenterology. 2015; 148(4):S278. View Publication
Oppenheim S, Wasan SK, Noronha A, Farraye FA, Miller H. Tu1371 A Retrospective Review of Response Rates and Risk of Complications Among Inflammatory Bowel Diseases Patients Treated With Vedolizumab. Gastroenterology. 2015; 148(4):S872. View Publication
Cleveland M, Yermakov S, Davis M, Campbell R, Huynh L, Farraye FA, Yenikomshian M. A Cost Comparison of Split-Dose Reduced-Volume oral Sulfate Solution (OSS) And Polyethylene Glycol With Electrolytes Solution (Peg-Els). Value in Health. 2015; 18(3):A197. View Publication
East JE, Farraye FA, Soetikno R. Endoscopic Approach to Resection of Polypoid and Non-Polypoid Dysplasia in IBD. Magnetic Resonance Enterography. 2015; 279-289. View Publication
Sands BE, Shafran I, Farraye FA, Smyth MD et. al. Sa1273 Efficacy and Safety of Retreatment With Vedolizumab in Patients With Crohn's Disease. Gastroenterology. 2015; 148(4):S278. View Publication

Qazi TM, O'Brien MJ, Farraye FA, Gould RW, Chen CA, Schroy PC. Epidemiology of goblet cell and microvesicular hyperplastic polyps. Am J Gastroenterol. 2014 Dec; 109(12):1922-32.View Related Profiles.

Farraye, Francis
O'Brien, Michael
Schroy, Paul
Gould, Ryan
Qazi, Taha

PMID: 25350766; DOI: 10.1038/ajg.2014.325;

Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE. High self-efficacy predicts adherence to surveillance colonoscopy in inflammatory bowel disease. Inflamm Bowel Dis. 2014 Sep; 20(9):1602-10. PMID: 25033161; DOI: 10.1097/MIB.0000000000000125;

Shah SA, Rubin DT, Farraye FA. Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease. Curr Gastroenterol Rep. 2014 Sep; 16(9):407. PMID: 25113042; DOI: 10.1007/s11894-014-0407-z;

Desalermos AP, Farraye FA, Wasan SK. Vaccinating the inflammatory bowel disease patient. Expert Rev Gastroenterol Hepatol. 2015 Jan; 9(1):91-102.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 25160668; DOI: 10.1586/17474124.2014.934672;

Desalermos AP, Frank S, Farraye FA. Recurrent Bell's palsy in a patient with Crohn's disease on methotrexate. J Clin Gastroenterol. 2014 Aug; 48(7):651-2.View Related Profiles.

Farraye, Francis
Frank, Samuel

PMID: 24492402; DOI: 10.1097/MCG.0000000000000079;

Rodriguez-Diaz E, Atkinson C, Jepeal LI, Berg A, Huang CS, Cerda SR, O'Brien MJ, Bigio IJ, Farraye FA, Singh SK. Elastic scattering spectroscopy as an optical marker of inflammatory bowel disease activity and subtypes. Inflamm Bowel Dis. 2014 Jun; 20(6):1029-36.View Related Profiles.

Huang, Christopher
Rodriguez-Diaz, Eladio
Farraye, Francis
Bigio, Irving
O'Brien, Michael
Cerda, Sandra
Singh, Satish

PMID: 24798637; PMCID: PMC4858439; DOI: 10.1097/MIB.0000000000000058;

Shergill AK, Farraye FA. Toward a consensus on endoscopic surveillance of patients with colonic inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2014 Jul; 24(3):469-81. PMID: 24975537; DOI: 10.1016/j.giec.2014.03.006;

Kwah J, Farraye FA. Current and Future Status for Evaluation of Dysplasia and Carcinoma in IBD. Curr Treat Options Gastroenterol. 2014 Mar; 12(1):90-102. PMID: 24477467

Wasan SK, Calderwood AH, Long MD, Kappelman MD, Sandler RS, Farraye FA. Immunization rates and vaccine beliefs among patients with inflammatory bowel disease: an opportunity for improvement. Inflamm Bowel Dis. 2014 Feb; 20(2):246-50.View Related Profiles.

Calderwood, Audrey
Farraye, Francis
Wasan, Sharmeel

PMID: 24374881; PMCID: PMC4393851; DOI: 10.1097/01.MIB.0000437737.68841.87;

Praveen P, Saleemuddin A, Farraye FA. Corrigendum to “Nocardia pneumonia in a patient with Crohn's disease receiving 6-mercaptopurine and infliximab” [J Crohns Colitis 8 (2014) 708–709]. Journal of Crohn s and Colitis. 2014; 8(12). View Publication
Miller H, Farraye FA. Pocket Guide to Gastrointestinal Drugs. 5-aminosalicylates. 2014; 82-99. View Publication
Farraye FA, Boden EK, Canavan JB, Moran CJ, Snapper SB et. al. Su1383 Pilot Study of Oral Delivery of Monoclonal Anti-CD3 Antibody (OKT3) in Moderate to Severe Ulcerative Colitis. Gastroenterology. 2014; 146(5):S-453. View Publication
Scriven M, Hewes PD, Knapp P, Mcdonnell ME, Alexanian S, Sentovich SM, Farraye FA, McAneny D. Su1118 The Development of a Standardized Peri-Operative Steroid Management Protocol for IBD Patients. Gastroenterology. 2014; 146(5):S-380. View Publication
Reich J, Wasan SK, Farraye FA. Su1110 Do Inadequacies in State Funding of Immunizations Create a Financial Hurdle to Vaccinations in Inflammatory Bowel Disease Patients?. Gastroenterology. 2014; 146(5):S377-S378. View Publication
Berg AM, Farraye FA. Medical Therapy of Ulcerative Colitis. Disease Modifiers in the Management of Ulcerative Colitis. 2014; 237-250. View Publication
Hannah M, Cohn H, Farraye FA. P-082 Small Intestinal Bacterial Overgrowth in Ulcerative Colitis Patients after Ileal Pouch-Anal Anastomosis. Inflammatory Bowel Diseases. 2014; 20. View Publication
Hamed K, Stewart K, Ananthakrishnan AN, Miller H, Nguyen D, Oppenheim S, Sauk J, Wasan S, Farraye FA, Yajnik V . P-067 Efficacy and Safety of Golimumab in Ulcerative Colitis: Experience From Two Large Boston Academic Hospitals. Inflammatory Bowel Diseases. 2014; 20:S54. View Publication

Saleemuddin A, Govender P, Govender PP, Farraye FA. Nocardia pneumonia in a patient with Crohn's disease receiving 6-mercaptopurine and infliximab. J Crohns Colitis. 2014 Jul; 8(7):708-9.View Related Profiles.

Farraye, Francis
Govender, Praveen

PMID: 24342764; DOI: 10.1016/j.crohns.2013.11.023;

Berg AM, Dam AN, Farraye FA. Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use. Gastroenterol Hepatol (N Y). 2013 Dec; 9(12):803-10. PMID: 24772046; PMCID: PMC3999994

Okafor PN, Stallwood CG, Nguyen L, Sahni D, Wasan SK, Farraye FA, Erim DO. Cost-effectiveness of nonmelanoma skin cancer screening in Crohn's disease patients. Inflamm Bowel Dis. 2013 Dec; 19(13):2787-95.View Related Profiles.

Sahni, Debjani
Farraye, Francis
Wasan, Sharmeel

PMID: 24193153; DOI: 10.1097/01.MIB.0000435850.17263.13;

Dam AN, Berg AM, Farraye FA. Environmental influences on the onset and clinical course of Crohn's disease-part 1: an overview of external risk factors. Gastroenterol Hepatol (N Y). 2013 Nov; 9(11):711-7. PMID: 24764788; PMCID: PMC3995193

Kanneganti M, Dehghani B, Steinberg J, Cerda S, Rybin D, Weinberg J, Farraye FA. Significance of granulomatous inflammation found on endoscopic biopsies or surgical resections on the severity of Crohn's disease. J Clin Gastroenterol. 2013 Nov-Dec; 47(10):894.View Related Profiles.

Farraye, Francis
Weinberg, Janice
Cerda, Sandra

PMID: 23632360; DOI: 10.1097/MCG.0b013e31829007d4;

Juillerat P, Wasan SK, Fowler SA, Friedman S, Pabby VK, Coukas JA, Barto AE, Pellish R, Germansky KA, Cheifetz AS, Korzenik JR, Farraye FA, Yajnik V. Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. Inflamm Bowel Dis. 2013 Oct; 19(11):2457-63.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 23962896; DOI: 10.1097/MIB.0b013e3182a32a0d;

Ordonez ME, Farraye FA, Di Palma JA. Endemic fungal infections in inflammatory bowel disease associated with anti-TNF antibody therapy. Inflamm Bowel Dis. 2013 Oct; 19(11):2490-500. PMID: 23694943; DOI: 10.1097/MIB.0b013e31828f1fba;

Okafor PN, Nunes DP, Farraye FA. Pneumocystis jiroveci pneumonia in inflammatory bowel disease: when should prophylaxis be considered? Inflamm Bowel Dis. 2013 Jul; 19(8):1764-71.View Related Profiles.

Nunes, David
Farraye, Francis

PMID: 23615530; DOI: 10.1097/MIB.0b013e318281f562;

Quinn AM, Farraye FA, Naini BV, Cerda S, Coukos J, Li Y, Khor T, Odze RD. Polypectomy is adequate treatment for adenoma-like dysplastic lesions (DALMs) in Crohn's disease. Inflamm Bowel Dis. 2013 May; 19(6):1186-93.View Related Profiles.

Farraye, Francis
Cerda, Sandra

PMID: 23567776; DOI: 10.1097/MIB.0b013e318280e749;

Berg AM, Farraye FA. Duodenal infusion of stool is more effective than vancomycin in patients with recurrent Clostridium difficile. Evid Based Med. 2013 Dec; 18(6):220-1. PMID: 23616152; DOI: 10.1136/eb-2013-101308;

Bennett M, Tompkins H, Seymour B, O'Brien MJ, Farraye FA. Spontaneous colonic perforation in a patient with collagenous colitis. Gastroenterol Hepatol (N Y). 2013 Apr; 9(4):262-4.View Related Profiles.

Farraye, Francis
O'Brien, Michael

PMID: 24711775; PMCID: PMC3977649

Long MD, Farraye FA, Okafor PN, Martin C, Sandler RS, Kappelman MD. Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Apr; 19(5):1018-24. PMID: 23478805; PMCID: PMC3879785; DOI: 10.1097/MIB.0b013e3182802a9b;

Rehman MQ, Beal D, Liang Y, Noronha A, Winter H, Farraye FA, Ganley-Leal L. B cells secrete eotaxin-1 in human inflammatory bowel disease. Inflamm Bowel Dis. 2013 Apr; 19(5):922-33.View Related Profiles.

Noronha, Ansu
Farraye, Francis

PMID: 23511032; DOI: 10.1097/MIB.0b013e3182802950;

Agarwal S, Stucchi AF, Dendrinos K, Cerda S, O'Brien MJ, Becker JM, Heeren T, Farraye FA. Is pyloric gland metaplasia in ileal pouch biopsies a marker for Crohn's disease? Dig Dis Sci. 2013 Oct; 58(10):2918-25.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
O'Brien, Michael
Cerda, Sandra
Heeren, Timothy

PMID: 23543088; DOI: 10.1007/s10620-013-2655-4;

Kalman RS, Gjede JM, Farraye FA. Pyostomatitis vegetans in a patient with fistulizing Crohn's disease. Clin Gastroenterol Hepatol. 2013 Dec; 11(12):A24. PMID: 23524131; DOI: 10.1016/j.cgh.2013.02.027;

Kwah J, Ditelberg JS, Farraye FA. Gender and location of CRC in IBD: implications for surveillance protocols. Inflamm Bowel Dis. 2013 Mar; 19(3):E44-6. PMID: 22508327; DOI: 10.1002/ibd.22984;

Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE. Factors that affect adherence to surveillance colonoscopy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Mar; 19(3):534-9. PMID: 23429444; DOI: 10.1097/MIB.0b013e3182802a3c;

Okafor PN, Wasan SK, Farraye FA. Pneumocystis jiroveci pneumonia in patients with inflammatory bowel disease: a survey of prophylaxis patterns among gastroenterology providers. Inflamm Bowel Dis. 2013 Mar-Apr; 19(4):812-7.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 23435401; DOI: 10.1097/MIB.0b013e31828029f4;

Miller HL, Farraye FA, Coukos J, Howard LA, Holick MF, Stucchi AF, Becker JM. Vitamin D deficiency and insufficiency are common in ulcerative colitis patients after ileal pouch-anal anastomosis. Inflamm Bowel Dis. 2013 Feb; 19(2):E25-6.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
Holick, Michael

PMID: 22275339; DOI: 10.1002/ibd.22890;

Rao S, Tkacz JN, Farraye FA. Portal venous gas after colonoscopy in two patients with Crohn's disease. Gastrointest Endosc. 2013 Feb; 77(2):316-8.View Related Profiles.

Farraye, Francis
Tkacz, Jaroslaw

PMID: 23317698; DOI: 10.1016/j.gie.2012.09.024;

Viani KL, Doyle LA, Farraye FA, Odze RD. Polypoid lesions in inflammatory bowel disease. Techniques in Gastrointestinal Endoscopy. 2013; 15(2):113-120. View Publication

Manolakis CS, Farraye FA, Di Palma JA. Crohn's disease: the subsequent visit. Gastroenterol Hepatol (N Y). 2013 Jan; 9(1):16-20. PMID: 24707229; PMCID: PMC3975973

Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis. 2013 Jan; 19(1):194-204. PMID: 22508484; DOI: 10.1002/ibd.22964;

Gillespie E, Leeman SE, Watts LA, Coukos JA, O'Brien MJ, Cerda SR, Farraye FA, Stucchi AF. Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer. J Crohns Colitis. 2013 Jun; 7(5):403-11.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
O'Brien, Michael
Cerda, Sandra
Leeman, Susan

PMID: 22921465; PMCID: PMC5279899; DOI: 10.1016/j.crohns.2012.08.003;

Roehrl MH, Farraye FA. Capillary hemangioma of the esophagus in a patient with systemic sclerosis and gastric antral vascular ectasia. Gastrointest Endosc. 2012 Aug; 76(2):418-9. PMID: 22817793; DOI: 10.1016/j.gie.2012.03.1394;

Humm SD, Farraye FA. "Cat scratch" colon in a female patient after a difficult screening colonoscopy. Gastroenterol Hepatol (N Y). 2012 May; 8(5):352. PMID: 22933869; PMCID: PMC3424433

Sinclair JA, Wasan SK, Farraye FA. Health maintenance in the inflammatory bowel disease patient. Gastroenterol Clin North Am. 2012 Jun; 41(2):325-37.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 22500521; DOI: 10.1016/j.gtc.2012.01.006;

Coukos JA, Howard LA, Weinberg JM, Becker JM, Stucchi AF, Farraye FA. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis. Dig Dis Sci. 2012 Jun; 57(6):1544-53.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
Weinberg, Janice

PMID: 22311367; DOI: 10.1007/s10620-012-2050-6;

Lowe R, Farraye FA, editors. Gastrointestinal Emergencies. Slack. 2012.
Eldib M, Farraye FA, Shah B. Sa1924 Implementation of Rapid Infliximab Infusion Protocol at an Academic Teaching Institution. Gastroenterology. 2012; 142(5):S360. View Publication
Farraye FA, Parks M, Singh S, Princen F. 108 Blood MicroRNA (miRNA) Expression Patterns Can Identify Inflammatory Bowel Disease (IBD) Patients With Dysplasia and Cancer. Gastroenterology. 2012; 142(5):S26. View Publication
Kakkar A, Farraye FA. Diagnosis and Management of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis. 2012; 701-711. View Publication

Gillespie E, Leeman SE, Watts LA, Coukos JA, O'Brien MJ, Cerda SR, Farraye FA, Stucchi AF, Becker JM. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer. Proc Natl Acad Sci U S A. 2011 Oct 18; 108(42):17420-5.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
O'Brien, Michael
Cerda, Sandra
Leeman, Susan

PMID: 21969570; PMCID: PMC3198340; DOI: 10.1073/pnas.1114275108;

Friedman S, Cheifetz AS, Farraye FA, Banks PA, Makrauer FL, Burakoff R, Farmer B, Torgersen LN, Wahl KE. Doctor message can alter patients' behavior and attitudes regarding inflammatory bowel disease and colon cancer. Inflamm Bowel Dis. 2012 Aug; 18(8):1531-9. PMID: 21928374; DOI: 10.1002/ibd.21861;

Soucy G, Wang HH, Farraye FA, Schmidt JF, Farris AB, Lauwers GY, Cerda SR, Dendrinos KG, Odze RD. Clinical and pathological analysis of colonic Crohn's disease, including a subgroup with ulcerative colitis-like features. Mod Pathol. 2012 Feb; 25(2):295-307.View Related Profiles.

Farraye, Francis
Cerda, Sandra

PMID: 21841769; DOI: 10.1038/modpathol.2011.120;

Kakkar A, Wasan SK, Farraye FA. Targeting mucosal healing in Crohn's disease. Gastroenterol Hepatol (N Y). 2011 Jun; 7(6):374-80.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 21869869; PMCID: PMC3151410

Mamula P, Tierney WM, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Kethu SR, Kwon RS, Pedrosa MC, Rodriguez SA, Wong Kee Song LM. Devices to improve colon polyp detection. Gastrointest Endosc. 2011 Jun; 73(6):1092-7.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 21628010; DOI: 10.1016/j.gie.2011.01.062;

Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011 Dec; 17(12):2536-40.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 21538710; DOI: 10.1002/ibd.21667;

Song LM, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM. Autofluorescence imaging. Gastrointest Endosc. 2011 Apr; 73(4):647-50.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 21296349; DOI: 10.1016/j.gie.2010.11.006;

Di Palma JA, Farraye FA. Crohn's disease: the first visit. Gastroenterol Hepatol (N Y). 2011 Mar; 7(3):163-9. PMID: 21528042; PMCID: PMC3079145

Gainsbury ML, Chu DI, Howard LA, Coukos JA, Farraye FA, Stucchi AF, Becker JM. Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis. J Gastrointest Surg. 2011 Mar; 15(3):397-403.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
Becker, James

PMID: 21246415; DOI: 10.1007/s11605-010-1385-6;

Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Song LM, Tierney WM. Computer-assisted personalized sedation. Gastrointest Endosc. 2011 Mar; 73(3):423-7.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 21237458; DOI: 10.1016/j.gie.2010.10.035;

Farraye FA, Nimitphong H, Stucchi A, Dendrinos K, Boulanger AB, Vijjeswarapu A, Tanennbaum A, Biancuzzo R, Chen TC, Holick MF. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis. 2011 Oct; 17(10):2116-21.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
Nimitphong, Hataikarn
Holick, Michael
Chen, Tai

PMID: 21910173; DOI: 10.1002/ibd.21595;

Farraye FA, Nimitphong H, Stucchi A, Dendrinos K, Boulanger AB, Vijjeswarapu A, Tanennbaum A, Biancuzzo R, Chen TC, Holick MF. Use of a novel vitamin d bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent crohn's disease. Inflamm Bowel Dis. 2011 Jan 6.View Related Profiles.

Farraye, Francis
Holick, Michael
Chen, Tai

PMID: 21213288; DOI: 10.1002/ibd.21595;

Lacy B. Farraye FA, series editor. Curbside Consultations in Functional Bowel Disorders. Slack. 2011.
Ditelberg JS, Farraye FA, Genta RM. A Descriptive Analysis of Colorectal Carcinoma in Patients With Ulcerative Colitis Seen Over a Three Year Period. Gastroenterology. 2011; 140(5). View Publication
Khurana H, Farraye FA, Levine J, Burakoff R, Coukos J, Cerda S, Odze RD. Hyperplastic and Serrated Polyps in Inflammatory Bowel Disease: A Clinicopathologic and Outcome Study. Gastroenterology. 2011; 140(5). View Publication
Rodriguez-Diaz E, Farraye FA, Bigio IJ, Singh SK. Optical Diagnosis of Crohn's Disease and Ulcerative Colitis Using Elastic-Scattering Spectroscopy. Gastroenterology. 2011; 140(5). View Publication
Kuhrana H, Farraye FA, Levine JS, Odze RD et. al. Laboratory Investigation. Clinicopathologic and Outcome Analysis of Serrated Polyps in Inflammatory Bowel Disease. 2011.
Wasan SK, Skolnik PR, Farraye FA. Response to Banaszkiewicz and Radzikowski. The American Journal of Gastroenterology. 2011; 106(3):546-7. View Publication
Rubin D, Friedman S, Farraye FA, editors. Farraye FA, series editor. Curbside Consultations in Inflammatory Bowel Disease. Slack. 2011.
Adler D. Farraye FA, series editor. Curbside Consultations in Gastrointestinal Cancers. Slack. 2011.

Huang CS, Farraye FA, Yang S, O'Brien MJ. The clinical significance of serrated polyps. Am J Gastroenterol. 2011 Feb; 106(2):229-40; quiz 241.View Related Profiles.

Huang, Christopher
Farraye, Francis
O'Brien, Michael
Yang, Shi

PMID: 21045813; DOI: 10.1038/ajg.2010.429;

Ganley-Leal LM, Liang Y, Jagannathan-Bogdan M, Farraye FA, Nikolajczyk BS. Differential regulation of TLR4 expression in human B cells and monocytes. Mol Immunol. 2010 Nov-Dec; 48(1-3):82-8.View Related Profiles.

Nikolajczyk, Barbara
Farraye, Francis
Ganley-Leal, Lisa

PMID: 20956019; PMCID: PMC2993761; DOI: 10.1016/j.molimm.2010.09.008;

Liang Y, Hasturk H, Elliot J, Noronha A, Liu X, Wetzler LM, Massari P, Kantarci A, Winter HS, Farraye FA, Ganley-Leal LM. Toll-like receptor 2 induces mucosal homing receptor expression and IgA production by human B cells. Clin Immunol. 2011 Jan; 138(1):33-40.View Related Profiles.

Noronha, Ansu
Farraye, Francis
Wetzler, Lee
Ganley-Leal, Lisa
Massari, Paola

PMID: 20947433; DOI: 10.1016/j.clim.2010.09.003;

Desilets D, Kaul V, Tierney WM, Banerjee S, Diehl DL, Farraye FA, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Wong Kee Song LM. Automated endoscope reprocessors. Gastrointest Endosc. 2010 Oct; 72(4):675-80.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 20883843; DOI: 10.1016/j.gie.2010.06.019;

Kethu SR, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Wong Kee Song LM, Tierney WM. Endoscopic tattooing. Gastrointest Endosc. 2010 Oct; 72(4):681-5.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 20883844; DOI: 10.1016/j.gie.2010.06.020;

McDonnell M, Liang Y, Noronha A, Coukos J, Kasper DL, Farraye FA, Ganley-Leal LM. Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis. 2011 Jan; 17(1):298-307.View Related Profiles.

Noronha, Ansu
Farraye, Francis
Ganley-Leal, Lisa
McDonnell, Marie

PMID: 20806343; DOI: 10.1002/ibd.21424;

Hetzel JT, Huang CS, Coukos JA, Omstead K, Cerda SR, Yang S, O'Brien MJ, Farraye FA. Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol. 2010 Dec; 105(12):2656-64.View Related Profiles.

Huang, Christopher
Farraye, Francis
O'Brien, Michael
Cerda, Sandra
Yang, Shi

PMID: 20717107; DOI: 10.1038/ajg.2010.315;

Wasan SK, Skolnik PR, Farraye FA. A 24-year-old patient with Crohn's disease starting immunosuppressive therapy: vaccination issues to consider. Clin Gastroenterol Hepatol. 2010 Dec; 8(12):1013-6.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 20656060; DOI: 10.1016/j.cgh.2010.07.001;

Kwon RS, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Mamula P, Pedrosa MC, Rodriguez SA, Varadarajulu S, Song LM, Tierney WM. Enteral nutrition access devices. Gastrointest Endosc. 2010 Aug; 72(2):236-48.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 20541746; DOI: 10.1016/j.gie.2010.02.008;

Pedrosa MC, Farraye FA, Shergill AK, Banerjee S, Desilets D, Diehl DL, Kaul V, Kwon RS, Mamula P, Rodriguez SA, Varadarajulu S, Song LM, Tierney WM. Minimizing occupational hazards in endoscopy: personal protective equipment, radiation safety, and ergonomics. Gastrointest Endosc. 2010 Aug; 72(2):227-35.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 20537638; DOI: 10.1016/j.gie.2010.01.071;

Rodriguez SA, Banerjee S, Desilets D, Diehl DL, Farraye FA, Kaul V, Kwon RS, Mamula P, Pedrosa MC, Varadarajulu S, Song LM, Tierney WM. Ultrathin endoscopes. Gastrointest Endosc. 2010 May; 71(6):893-8.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 20438882; DOI: 10.1016/j.gie.2010.01.022;

Diehl DL, Tierney WM, Adler DG, Conway JD, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA. The role of the U.S. Food and Drug Administration in device evaluation and monitoring. Gastrointest Endosc. 2010 Jul; 72(1):5-10.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 20421100; DOI: 10.1016/j.gie.2010.01.024;

Kaul V, Adler DG, Conway JD, Farraye FA, Kantsevoy SV, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM. Interventional EUS. Gastrointest Endosc. 2010 Jul; 72(1):1-4.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 20381044; DOI: 10.1016/j.gie.2010.01.023;

Kethu SR, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM. ERCP cannulation and sphincterotomy devices. Gastrointest Endosc. 2010 Mar; 71(3):435-45.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 20189502; DOI: 10.1016/j.gie.2009.07.038;

Wasan SK, Farraye FA. Do 5-ASAs prevent colorectal neoplasia in patients with ulcerative colitis? Still no answers. Inflamm Bowel Dis. 2010 Feb; 16(2):358-60.View Related Profiles.

Farraye, Francis
Wasan, Sharmeel

PMID: 19685451; DOI: 10.1002/ibd.21065;

Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb; 138(2):746-74, 774.e1-4; quiz e12-3. PMID: 20141809; DOI: 10.1053/j.gastro.2009.12.035;

Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T, McLeod R, Burgart LJ, Allen J, Brill JV. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb; 138(2):738-45. PMID: 20141808; DOI: 10.1053/j.gastro.2009.12.037;

Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010 Jun; 105(6):1231-8.View Related Profiles.

Farraye, Francis
Skolnik, Paul
Wasan, Sharmeel

PMID: 20104218; DOI: 10.1038/ajg.2009.733;

Farraye FA. 50 Questions About Ulcerative Colitis. A Patient’s Guide. Jones and Bartlett. 2010.
Gonzales KD, Gupta A, Tkacz JN, Becker J. M1623 Portal Venous Thrombus (PVT) Following Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis (IPAA) for Ulcerative Colitis (UC): Does the Laparoscopic Approach Increase the Risk of PVT?. Gastroenterology. 2010; 138(5). View Publication
Nee JW, Reboucas BR, Gitin Y, O'Brien MJ, Brody JS, Farraye FA, Offner GD. S1940 Differences in Mucin Gene Expression in Rectal Brushings From Ulcerative Colitis Patients With and Without Low-Grade Dysplasia. Gastroenterology. 2010; 138(5). View Publication
Gainsbury ML, Chu D, Howard LA, Coukos J, Hetzel J, Farraye FA, Stucchi AF, Becker J. 1045 Preoperative Treatment With Infliximab is Not Associated With an Increased Risk of Short-Term Postoperative Complications After Colectomy With Ileal Pouch-Anal Anastomosis. Gastroenterology. 2010; 138(5). View Publication
Wasan SK, Coukos J, Farraye FA. T1311 Gastroenterologist (GI) Knowledge and Behavior in Vaccinating the Inflammatory Bowel Disease (IBD) Patient. Gastroenterology. 2010; 138(5). View Publication
Hetzel J, Coukos J, Huang CS, Farraye FA et. al. S1153 Variability in Serrated Polyp Detection by Endoscopist and Pathologist in a Cohort of Average Risk Screening Colonoscopies. Gastroenterology. 2010; 138(5). View Publication
Gillespie E, Hetzel J, Coukos J, Farraye FA, Cerda S, O'Brien MJ, Leeman SE, Stucchi AF, Becker J. M1951 Gene Expression of the Truncated Neurokinin1 Receptor as Well as Two NF-kB Subunits is Altered in the Transition of Colonic Epithelial Cells From Quiescent Colitis to High Grade Dysplasia to Carcinoma in Colitis Associated Colorectal Cancer. Gastroenterology. 2010; 138(5). View Publication
Farraye FA, Wishnia S, Sullivan M, Servais E, Becker JM et. al. Outcomes after Completion Mucosectomy for Retained Rectal Mucosa Following Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis. Journal of Surgical Research. 2010; 158(2):176. View Publication

Adler DG, Conway JD, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM. Biliary and pancreatic stone extraction devices. Gastrointest Endosc. 2009 Oct; 70(4):603-9.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 19788977; DOI: 10.1016/j.gie.2009.06.015;

Kwon RS, Wong Kee Song LM, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Mamula P, Pedrosa MC, Rodriguez SA, Tierney WM. Endocytoscopy. Gastrointest Endosc. 2009 Oct; 70(4):610-3.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 19788978; DOI: 10.1016/j.gie.2009.06.030;

Tierney WM, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Pedrosa MC, Rodriguez SA. Overtube use in gastrointestinal endoscopy. Gastrointest Endosc. 2009 Nov; 70(5):828-34.View Related Profiles.

Farraye, Francis
Pedrosa, Marcos

PMID: 19703691; DOI: 10.1016/j.gie.2009.06.014;

Noronha AM, Liang Y, Hetzel JT, Hasturk H, Kantarci A, Stucchi A, Zhang Y, Nikolajczyk BS, Farraye FA, Ganley-Leal LM. Hyperactivated B cells in human inflammatory bowel disease. J Leukoc Biol. 2009 Oct; 86(4):1007-16.View Related Profiles.

Noronha, Ansu
Stucchi, Arthur
Nikolajczyk, Barbara
Farraye, Francis
Ganley-Leal, Lisa

PMID: 19589946; PMCID: PMC2796625; DOI: 10.1189/jlb.0309203;

Kantsevoy SV, Adler DG, Conway JD, Diehl DL, Farraye FA, Kaul V, Kethu SR, Kwon RS, Mamula P, Rodriguez SA, Tierney WM. Confocal laser endomicroscopy. Gastrointest Endosc. 2009 Aug; 70(2):197-200. PMID: 19559426; DOI: 10.1016/j.gie.2009.04.002;

Joo M, Abreu-e-Lima P, Farraye F, Smith T, Swaroop P, Gardner L, Lauwers GY, Odze RD. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. Am J Surg Pathol. 2009 Jun; 33(6):854-62. PMID: 19295408; DOI: 10.1097/PAS.0b013e318196d018;

Mamula P, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Rodriguez SA, Tierney WM. Colonoscopy preparation. Gastrointest Endosc. 2009 Jun; 69(7):1201-9. PMID: 19481646; DOI: 10.1016/j.gie.2009.01.035;

Conway JD, Adler DG, Diehl DL, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Rodriguez SA, Tierney WM. Endoscopic hemostatic devices. Gastrointest Endosc. 2009 May; 69(6):987-96. PMID: 19410037; DOI: 10.1016/j.gie.2008.12.251;

Diehl DL, Adler DG, Conway JD, Farraye FA, Kantsevoy SV, Kaul V, Kethu SR, Kwon RS, Mamula P, Rodriguez SA, Tierney WM. Endoscopic retrieval devices. Gastrointest Endosc. 2009 May; 69(6):997-1003. PMID: 19410038; DOI: 10.1016/j.gie.2009.01.005;

Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis. 2009 Apr; 15(4):630-8. PMID: 18942763; PMCID: PMC2753500; DOI: 10.1002/ibd.20766;

Farraye FA, Adler DG, Chand B, Conway JD, Diehl DL, Kantsevoy SV, Kwon RS, Mamula P, Rodriguez SA, Shah RJ, Wong Kee Song LM, Tierney WM. Update on CT colonography. Gastrointest Endosc. 2009 Mar; 69(3 Pt 1):393-8. PMID: 19231482; DOI: 10.1016/j.gie.2008.10.009;

Brown A, Tenner S. Farraye FA, series editor. Curbside Consultations in Pancreatic Disorders. Slack. 2009.
Jacobson BC, Crawford JM, Farraye FA. GI Tract Endoscopic and Tissue Processing Techniques and Normal Histology. 2009. View Publication
Pratap A, Farraye FA. Screening and Surveillance Guidelines in Gastroenterology. 2009. View Publication
Soucy G, Schmidt J, Greenberg J, Cerda S, Agarwal S, Dendrinos K, Farraye FA, Farris AB, Lauwers GY, Wang HH, Odze RD. S1225 Ulcerative Colitis-Like Crohn's Disease: A Clinical/Pathologic and Outcome Study. Gastroenterology. 2009; 136(5). View Publication
Noronha AM, Liang Y, Farraye FA, Ganley-Leal LM et. al. S1727 TLR2 Regulates B Cell Response and Function in Inflammatory Bowel Disease. Gastroenterology. 2009; 136(5). View Publication

Dendrinos K, Cerda S, Farraye FA. The "cecal patch" in patients with ulcerative colitis. Gastrointest Endosc. 2008 Nov; 68(5):1006-7; discussion 1007.View Related Profiles.

Farraye, Francis
Cerda, Sandra

PMID: 18620347; DOI: 10.1016/j.gie.2008.04.003;

Kantsevoy SV, Adler DG, Conway JD, Diehl DL, Farraye FA, Kwon R, Mamula P, Rodriguez S, Shah RJ, Wong Kee Song LM, Tierney WM. Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc. 2008 Jul; 68(1):11-8. PMID: 18577472; DOI: 10.1016/j.gie.2008.01.037;

Shah RJ, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kwon R, Mamula P, Rodriguez S, Wong Kee Song LM, Tierney WM. Cholangiopancreatoscopy. Gastrointest Endosc. 2008 Sep; 68(3):411-21. PMID: 18538326; DOI: 10.1016/j.gie.2008.02.033;

Yantiss RK, Das KM, Farraye FA, Odze RD. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis. Am J Surg Pathol. 2008 Jun; 32(6):844-50. PMID: 18408596; DOI: 10.1097/PAS.0b013e31815b121c;

Song LM, Adler DG, Conway JD, Diehl DL, Farraye FA, Kantsevoy SV, Kwon R, Mamula P, Rodriguez B, Shah RJ, Tierney WM. Narrow band imaging and multiband imaging. Gastrointest Endosc. 2008 Apr; 67(4):581-9. PMID: 18374021; DOI: 10.1016/j.gie.2008.01.013;

Conway JD, Adler DG, Diehl DL, Farraye FA, Kantsevoy SV, Kwon R, Mamula P, Rodriguez B, Shah RJ, Song LM, Tierney WM. Endoscopic electronic medical record systems. Gastrointest Endosc. 2008 Apr; 67(4):590-4. PMID: 18374022; DOI: 10.1016/j.gie.2008.01.040;

Srivastava A, Redston M, Farraye FA, Yantiss RK, Odze RD. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol. 2008 Feb; 32(2):296-303. PMID: 18223333; DOI: 10.1097/PAS.0b013e318150d51b;

Noronha A, Liang Y, Harnett W, Harnett M, Stucchi A, Becker J, Farraye FA, Ganley-Leal LM. TILR2 and TLR4 regulate B cell responses in human inflammatory bowel disease. Inflammatory Bowel Diseases. 2008; 14:S8. View Publication
Torgersen LN, Cheifetz AS, Farraye FA, Friedman S. S1214 How Do IBD Patients Get Their Information? a Look At IBD Information Resources and Perception of Doctor Message in Patients with Extensive Crohn's or Ulcerative Colitis. Gastroenterology. 2008; 134(4). View Publication
Gitin Y, Farraye FA, Zhang X, Liu G, Spira A, Brody JS. M2066 Evaluation of Global Gene Expression in Rectal Mucosa Obtained By a Non-Invasive Technique in Patients with Ulcerative Colitis. Gastroenterology. 2008; 134(4). View Publication
Dendrinos K, Stucchi AF, Becker J, Chen TC, Mathieu J, Heeren T, Kantarci A, Blackwood A, Bushell K, Holick MF, Farraye FA. T1150 Efficacy of Two Different Weekly Doses of Vitamin D (400 Iu and 50,000 Iu) in Patients with Crohn's Disease in Improving Vitamin D Nutritional Status. Gastroenterology. 2008; 134(4). View Publication
Huang CS, Farraye FA, Shepherd C, O'Brien MJ. T2038 A Case-Control Study of the Risk Factors for Advanced Serrated Polyps. Gastroenterology. 2008; 134(4). View Publication
Gitin Y, Farraye FA, Atkinson CD, Rodriguez-Diaz E, Cerda S, O'Brien MJ, Bigio IJ, Singh SK. T1850 Elastic Scattering Spectroscopy (Ess) Guided Forceps for the Diagnosis of Inflammatory Bowel Disease (IBD). Gastroenterology. 2008; 134(4). View Publication
O'Brien MJ, Yang S, Huang CS, Shepherd C, Cerda S, Farraye FA. The serrated polyp pathway to colorectal carcinoma. Diagnostic Histopathology. 2008; 14(2):78-94. View Publication
Schiffman M. Farraye FA, series editor. Curbside Consultations in Liver Disease. Slack. 2008.
Katz P. Farraye FA, series editor. Curbside Consultations in GERD. Slack. 2008.
Cash B. Farraye FA, series editor. Curbside Consultations in Colonic Disorders. Slack. 2008.
Lo S, Leung J. Farraye FA, series editor. Curbside Consultations in Endoscopy. Slack. 2008.

Cole JA, Farraye FA, Cabral HJ, Zhang Y, Rothman KJ. Irritable bowel syndrome and hysterectomy: a sequence symmetry analysis. Epidemiology. 2007 Nov; 18(6):837-8.View Related Profiles.

Farraye, Francis
Cabral, Howard
Rothman, Kenneth

PMID: 18049197

Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007 Oct; 13(10):1250-5. PMID: 17567869

Gitin Y, Farraye FA. Can regular use of 5-ASAs protect against the development of dysplasia and colorectal cancer in patients with ulcerative colitis? Inflamm Bowel Dis. 2007 Aug; 13(8):1051-2. PMID: 17427239

Farraye FA, Waye JD, Moscandrew M, Heeren TC, Odze RD. Variability in the diagnosis and management of adenoma-like and non-adenoma-like dysplasia-associated lesions or masses in inflammatory bowel disease: an Internet-based study. Gastrointest Endosc. 2007 Sep; 66(3):519-29.View Related Profiles.

Farraye, Francis
Heeren, Timothy

PMID: 17640638

Hornick JL, Farraye FA, Odze RD. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas. Am J Surg Pathol. 2007 Feb; 31(2):207-15. PMID: 17255765

Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Incidence of IBS in a cohort of people with asthma. Dig Dis Sci. 2007 Feb; 52(2):329-35.View Related Profiles.

Farraye, Francis
Cabral, Howard
Rothman, Kenneth
Zhang, Yuqing

PMID: 17211701

O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, Amorosino M, Farraye FA. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006 Dec; 30(12):1491-501.View Related Profiles.

Huang, Christopher
Farraye, Francis
Xu, Huihong
O'Brien, Michael
Yang, Shi

PMID: 17122504

Nadgir RN, Soto JA, Dendrinos K, Lucey BC, Becker JM, Farraye FA. MRI of complicated pouchitis. AJR Am J Roentgenol. 2006 Oct; 187(4):W386-91.View Related Profiles.

Farraye, Francis
Soto, Jorge
Nadgir, Rohini

PMID: 16985109

Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006; 6:26.View Related Profiles.

Farraye, Francis
Cabral, Howard
Rothman, Kenneth
Zhang, Yuqing

PMID: 17007634; PMCID: PMC1592499; DOI: 10.1186/1471-230X-6-26;

Mishkin DS, Van Deinse W, Becker JM, Farraye FA. Successful use of adalimumab (Humira) for Crohn's disease in pregnancy. Inflamm Bowel Dis. 2006 Aug; 12(8):827-8. PMID: 16917239

Burakoff R, Barish CF, Riff D, Pruitt R, Chey WY, Farraye FA, Shafran I, Katz S, Krone CL, Vander Vliet M, Stevens C, Sherman ML, Jacobson E, Bleday R. A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease. Inflamm Bowel Dis. 2006 Jul; 12(7):558-65. PMID: 16804392

Farraye FA, Schroy PC. Chromoendoscopy: a new vision for colonoscopic surveillance in IBD. Gastroenterology. 2006 Jul; 131(1):323-5; discussion 325-6.View Related Profiles.

Farraye, Francis
Schroy, Paul

PMID: 16831617

Dendrinos KG, Becker JM, Stucchi AF, Saubermann LJ, LaMorte W, Farraye FA. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. J Gastrointest Surg. 2006 Jul-Aug; 10(7):1060-4.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
LaMorte, Wayne

PMID: 16843878

Fix OK, Simon JT, Farraye FA, Oviedo JA, Pratt DS, Chen WT, Cave DR. Obscure gastrointestinal hemorrhage from mesenteric varices diagnosed by video capsule endoscopy. Dig Dis Sci. 2006 Jul; 51(7):1169-74.View Related Profiles.

Farraye, Francis
Oviedo, Jaime

PMID: 16944004

Liu TC, Amorosino MS, Cerda S, Farraye FA. Mycophenolate mofetil-associated enterocolitis. Gastrointest Endosc. 2006 Apr; 63(4):707-8, discussion 708.View Related Profiles.

Farraye, Francis
Cerda, Sandra

PMID: 16564882

Yantiss RK, Farraye FA, O'Brien MJ, Fruin AB, Stucchi AF, Becker JM, Reddy SI, Odze RD. Prognostic significance of superficial fissuring ulceration in patients with severe "indeterminate" colitis. Am J Surg Pathol. 2006 Feb; 30(2):165-70.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
O'Brien, Michael

PMID: 16434889

Hornick JL, Farraye FA, Odze RD. Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett's-associated adenocarcinoma. Am J Surg Pathol. 2006 Jan; 30(1):28-35. PMID: 16330939

Farraye FA, Forse HA, eds. Bariatric Surgery: A Primer for your Practice. Slack. 2006.
Huang CS, Farraye FA. Complications following Bariatric Surgery. Techniques in Gastrointestinal Endoscopy. 2006; 8(2):54-65. View Publication
Dysplasia and Cancer in Inflammatory Bowel Disease. Gastroenterology Clinics of North America. Farraye FA, guest editor. Elsevier. 2006.

Pabby A, Suneja A, Heeren T, Farraye FA. Flexible sigmoidoscopy for colorectal cancer screening in the elderly. Dig Dis Sci. 2005 Nov; 50(11):2147-52.View Related Profiles.

Farraye, Francis
Heeren, Timothy

PMID: 16240230

Haskell H, Andrews CW, Reddy SI, Dendrinos K, Farraye FA, Stucchi AF, Becker JM, Odze RD. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol. 2005 Nov; 29(11):1472-81.View Related Profiles.

Stucchi, Arthur
Farraye, Francis

PMID: 16224214

Lorber J, Kalish J, Farraye FA, Cerda S, Babineau TJ. Glomus tumor of the gastric antrum: case report. Curr Surg. 2005 Jul-Aug; 62(4):436-8.View Related Profiles.

Farraye, Francis
Kalish, Jeffrey
Cerda, Sandra

PMID: 15964471

Emmons KM, McBride CM, Puleo E, Pollak KI, Clipp E, Kuntz K, Marcus BH, Napolitano M, Onken J, Farraye F, Fletcher R. Project PREVENT: a randomized trial to reduce multiple behavioral risk factors for colon cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1453-9. PMID: 15941955

Yung K, Oviedo J, Farraye FA, Becker JM, Andrews CW, Lichtenstein D. Ampullary stenosis with biliary obstruction in duodenal Crohn's disease: a case report and review of the literature. Dig Dis Sci. 2005 Jun; 50(6):1118-21.View Related Profiles.

Lichtenstein, David
Farraye, Francis
Oviedo, Jaime

PMID: 15986865

Ahn LB, Huang CS, Forse RA, Hess DT, Andrews C, Farraye FA. Crohn's disease after gastric bypass surgery for morbid obesity: is there an association? Inflamm Bowel Dis. 2005 Jun; 11(6):622-4.View Related Profiles.

Huang, Christopher
Hess, Donald
Farraye, Francis

PMID: 15905716

Levin TR, Farraye FA, Schoen RE, Hoff G, Atkin W, Bond JH, Winawer S, Burt RW, Johnson DA, Kirk LM, Litin SC, Rex DK. Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut. 2005 Jun; 54(6):807-13. PMID: 15888789; PMCID: PMC1774519; DOI: 10.1136/gut.2004.052282;

Emmons KM, McBride CM, Puleo E, Pollak KI, Marcus BH, Napolitano M, Clipp E, Onken J, Farraye FA, Fletcher R. Prevalence and predictors of multiple behavioral risk factors for colon cancer. Prev Med. 2005 May; 40(5):527-34. PMID: 15749134

Majumdar SR, Ross-Degnan D, Farraye FA, Lee M, Kemp JA, Lecates RF, Henning JM, Tunis SR, Schrammel P, Soumerai SB. Controlled trial of interventions to increase testing and treatment for Helicobacter pylori and reduce medication use in patients with chronic acid-related symptoms. Aliment Pharmacol Ther. 2005 Apr 15; 21(8):1029-39. PMID: 15813839

Schroy PC, Lal SK, Wilson S, Heeren T, Farraye FA. Deficiencies in knowledge and familial risk communication among colorectal adenoma patients. J Clin Gastroenterol. 2005 Apr; 39(4):298-302.View Related Profiles.

Farraye, Francis
Schroy, Paul
Heeren, Timothy

PMID: 15758623

Huang CS, Lal SK, Farraye FA. Colorectal cancer screening in average risk individuals. Cancer Causes Control. 2005 Mar; 16(2):171-88.View Related Profiles.

Huang, Christopher
Farraye, Francis

PMID: 15868457

Huang CS, Farraye FA. Endoscopy in the bariatric surgical patient. Gastroenterol Clin North Am. 2005 Mar; 34(1):151-66.View Related Profiles.

Huang, Christopher
Farraye, Francis

PMID: 15823445

Wolfe MM, editor. Section editors: Davis GL, Giannella RA, Farraye FA, Steer M, Malagelada J. Therapy of Digestive Disorders. Elsevier Company. Philadelphia. 2005.
Haskell HL, Andrews C, Reddy SI, Dendrinos K, Farraye FA, Stucchi AF, Becker J, Odze RD. Backwash Ileitis Is Not Associated With an Increased Risk of Neoplasia in Ulcerative Colitis. Gastroenterology. 2005; 129(3):1106. View Publication

Fix OK, Soto JA, Andrews CW, Farraye FA. Gastroduodenal Crohn's disease. Gastrointest Endosc. 2004 Dec; 60(6):985.View Related Profiles.

Farraye, Francis
Soto, Jorge

PMID: 15605018

Huang CS, O'brien MJ, Yang S, Farraye FA. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am J Gastroenterol. 2004 Nov; 99(11):2242-55.View Related Profiles.

Huang, Christopher
Farraye, Francis
O'Brien, Michael
Yang, Shi

PMID: 15555008

Yang S, Farraye FA, Mack C, Posnik O, O'Brien MJ. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004 Nov; 28(11):1452-9.View Related Profiles.

Farraye, Francis
O'Brien, Michael
Yang, Shi

PMID: 15489648

Farraye F, Schroy PC. Tailoring use of screening colonoscopy: are we up to the challenge? Gastroenterology. 2004 Aug; 127(2):673-5.View Related Profiles.

Farraye, Francis
Schroy, Paul

PMID: 15300599

Yantiss RK, Sapp HL, Farraye FA, El-Zammar O, O'Brien MJ, Fruin AB, Stucchi AF, Brien TP, Becker JM, Odze RD. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol. 2004 Aug; 28(8):999-1006.View Related Profiles.

Stucchi, Arthur
Farraye, Francis
O'Brien, Michael

PMID: 15252305

Odze RD, Farraye FA, Hecht JL, Hornick JL. Long-term follow-up after polypectomy treatment for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol. 2004 Jul; 2(7):534-41. PMID: 15224277

Farraye FA, Horton K, Hersey H, Trnka Y, Heeren T, Provenzale D. Screening flexible sigmoidoscopy using an upper endoscope is better tolerated by women. Am J Gastroenterol. 2004 Jun; 99(6):1074-80.View Related Profiles.

Farraye, Francis
Heeren, Timothy

PMID: 15180728

Mutinga ML, Odze RD, Wang HH, Hornick JL, Farraye FA. The clinical significance of right-sided colonic inflammation in patients with left-sided chronic ulcerative colitis. Inflamm Bowel Dis. 2004 May; 10(3):215-9. PMID: 15290914

O'Brien MJ, Yang S, Clebanoff JL, Mulcahy E, Farraye FA, Amorosino M, Swan N. Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol. 2004 Apr; 28(4):423-34.View Related Profiles.

Farraye, Francis
O'Brien, Michael
Yang, Shi

PMID: 15087661

Shaz BH, Reddy SI, Ayata G, Brien T, Farraye FA, Antonioli DA, Odze RD, Wang HH. Sequential clinical and histopathological changes in collagenous and lymphocytic colitis over time. Mod Pathol. 2004 Apr; 17(4):395-401. PMID: 14976531

Clipp EC, Carver EH, Pollak KI, Puleo E, Emmons KM, Onken J, Farraye FA, McBride CM. Age-related vulnerabilities of older adults with colon adenomas: evidence from Project Prevent. Cancer. 2004 Mar 1; 100(5):1085-94. PMID: 14983506

Sangha S, Soto JA, Becker JM, Farraye FA. Primary epiploic appendagitis: an underappreciated diagnosis. A case series and review of the literature. Dig Dis Sci. 2004 Feb; 49(2):347-50.View Related Profiles.

Farraye, Francis
Soto, Jorge

PMID: 15104382

Farraye FA, Wong M, Hurwitz S, Puleo E, Emmons K, Wallace MB, Fletcher RH. Barriers to endoscopic colorectal cancer screening: are women different from men? Am J Gastroenterol. 2004 Feb; 99(2):341-9. PMID: 15046227

Glickman JN, Bousvaros A, Farraye FA, Zholudev A, Friedman S, Wang HH, Leichtner AM, Odze RD. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004 Feb; 28(2):190-7. PMID: 15043308

Huang CS, de las Morenas A, Farraye FA. Focal intestinal lymphangiectasia. Gastrointest Endosc. 2004 Jan; 59(1):74.View Related Profiles.

De Las Morenas, Antonio
Huang, Christopher
Farraye, Francis

PMID: 14722552

Huang CS, Forse RA, Jacobson BC, Farraye FA. Endoscopic findings and their clinical correlations in patients with symptoms after gastric bypass surgery. Gastrointest Endosc. 2003 Dec; 58(6):859-66.View Related Profiles.

Jacobson, Brian
Huang, Christopher
Farraye, Francis

PMID: 14652553

Majumdar SR, Soumerai SB, Farraye FA, Lee M, Kemp JA, Henning JM, Schrammel P, LeCates RF, Ross-Degnan D. Chronic acid-related disorders are common and underinvestigated. Am J Gastroenterol. 2003 Nov; 98(11):2409-14. PMID: 14638341

Kissin EY, Corbo JC, Farraye FA, Merkel PA. Colchicine myopathy in a patient with familial Mediterranean fever and normal renal function. Arthritis Rheum. 2003 Aug 15; 49(4):614-6.View Related Profiles.

Kissin, Eugene
Farraye, Francis
Merkel, Peter

PMID: 12910572

Huang CS, Becker JM, Farraye FA. Successful closure of ileal pouch-vaginal fistulas with infliximab. Gastroenterology. 2003 Aug; 125(2):631-3; author reply 633.View Related Profiles.

Huang, Christopher
Farraye, Francis

PMID: 12891580

Stockwell DH, Woo P, Jacobson BC, Remily R, Syngal S, Wolf J, Farraye FA. Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol. 2003 Aug; 98(8):1875-80.View Related Profiles.

Jacobson, Brian
Farraye, Francis

PMID: 12907347

Eloubeidi MA, Wallace MB, Desmond R, Farraye FA. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer. Am J Gastroenterol. 2003 Jul; 98(7):1634-9. PMID: 12873591

Friedman S, Odze RD, Farraye FA. Management of neoplastic polyps in inflammatory bowel disease. Inflamm Bowel Dis. 2003 Jul; 9(4):260-6. PMID: 12902849

Yantiss RK, Odze RD, Farraye FA, Rosenberg AE. Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol. 2003 Jun; 27(6):811-7. PMID: 12766586

Fix O, Simon JT, Cave DR, Oviedo JA. Jejunal varices as a cause of obscure overt gastrointestinal hemorrhage. The American Journal of Gastroenterology. 2003; 98(9). View Publication
Schroy PC, Lal S, Wilson S, Farraye FA et. al. Familial colorectal cancer (CRC) risk communication among colorectal adenoma (CRA) patients. Gastroenterology. 2003; 124(4). View Publication
Huang CS, Forse R, Jacobson BC, Farraye FA. A study of the endoscopic findings and their clinical correlations in symptomatic gastric bypass patients. The American Journal of Gastroenterology. 2003; 98(9). View Publication

Liu JJ, Piper JK, Glickman JN, Farraye FA. Successful treatment of giant cell hepatitis with Rebetron (interferon/ribavirin). Am J Gastroenterol. 2003 Jan; 98(1):223-4. PMID: 12526974

Lembo A, Weber HC, Farraye FA. Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder. Drugs. 2003; 63(18):1895-905. PMID: 12930162

Yantiss RK, Farraye FA, Yung K, Odze RD et. al. Clinical and prognostic significance of early fissuring ulceration in chronic ulcerative colitis. Gastroenterology. 2003; 124(4). View Publication

Sapp H, Ithamukkala S, Brien TP, Ayata G, Shaz B, Dorfman DM, Wang HH, Antonioli DA, Farraye FA, Odze RD. The terminal ileum is affected in patients with lymphocytic or collagenous colitis. Am J Surg Pathol. 2002 Nov; 26(11):1484-92. PMID: 12409725

Ayata G, Ithamukkala S, Sapp H, Shaz BH, Brien TP, Wang HH, Antonioli DA, Farraye FA, Odze RD. Prevalence and significance of inflammatory bowel disease-like morphologic features in collagenous and lymphocytic colitis. Am J Surg Pathol. 2002 Nov; 26(11):1414-23. PMID: 12409717

Lal SK, Clarke PD, Becker JM, Farraye FA. Colouterine fistula. Am J Gastroenterol. 2002 Sep; 97(9):2473-4. PMID: 12358282

Huang C, Lichtenstein DR, Farraye FA. Ureterosigmoidostomy. Gastrointest Endosc. 2002 Aug; 56(2):272.View Related Profiles.

Huang, Christopher
Lichtenstein, David
Farraye, Francis

PMID: 12145609

Yantiss RK, Chang HK, Farraye FA, Compton CC, Odze RD. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors. Am J Surg Pathol. 2002 Jul; 26(7):893-901. PMID: 12131156

Oviedo J, Barrison A, Farraye FA. Osler-Weber-Rendu syndrome. Gastrointest Endosc. 2002 Jun; 55(7):910.View Related Profiles.

Farraye, Francis
Oviedo, Jaime

PMID: 12024150

Bernstorff WV, Glickman JN, Odze RD, Farraye FA, Joo HG, Goedegebuure PS, Eberlein TJ. Fas (CD95/APO-1) and Fas ligand expression in normal pancreas and pancreatic tumors. Implications for immune privilege and immune escape. Cancer. 2002 May 15; 94(10):2552-60. PMID: 12173320

Talwalkar JA, Ruymann FW, Marcoux P, Farraye FA. Recurrent thrombotic thrombocytopenic purpura (TTP) as a complication of acute relapsing pancreatitis. Dig Dis Sci. 2002 May; 47(5):1096-9. PMID: 12018906

Pabby A, Suneja A, Heeren T, Farraye FA. Success of physician versus nonphysician endoscopists in performing screening flexible sigmoidoscopy in the elderly population. The American Journal of Gastroenterology. 2002; 97(9). View Publication

Farraye FA, Wallace M. Clinical significance of small polyps found during screening with flexible sigmoidoscopy. Gastrointest Endosc Clin N Am. 2002 Jan; 12(1):41-51. PMID: 11916160

Huang CS, Farraye FA. WHAT IS THE APPROPRIATE INTERVAL FOR REPEAT COLONOSCOPY IN PATIENTS WITH AND WITHOUT ADENOMATOUS POLYPS FOUND ON SCREENING COLONOSCOPY?. Evidence-Based Gastroenterology. 2002; 3(3):90-91. View Publication

Oviedo J, Swan N, Farraye FA. Gastric xanthomas. Am J Gastroenterol. 2001 Nov; 96(11):3216-8.View Related Profiles.

Farraye, Francis
Oviedo, Jaime

PMID: 11721787

Oviedo J, Farraye FA. Self-care for the inflammatory bowel disease patient: what can the professional recommend? Semin Gastrointest Dis. 2001 Oct; 12(4):223-36.View Related Profiles.

Farraye, Francis
Oviedo, Jaime

PMID: 11726076

Horton K, Reffel A, Rosen K, Farraye FA. Training of nurse practitioners and physician assistants to perform screening flexible sigmoidoscopy. J Am Acad Nurse Pract. 2001 Oct; 13(10):455-9.View Related Profiles.

Reffel, Angela
Farraye, Francis

PMID: 11930767

Jacobson BC, Hirsch MS, Lee JH, Van Dam J, Shoji B, Farraye FA. Multiple asymptomatic plexiform schwannomas of the sigmoid colon: a case report and review. Gastrointest Endosc. 2001 Jun; 53(7):801-4.View Related Profiles.

Jacobson, Brian
Farraye, Francis

PMID: 11375596

Brien TP, Farraye FA, Odze RD. Gastric dysplasia-like epithelial atypia associated with chemoradiotherapy for esophageal cancer: a clinicopathologic and immunohistochemical study of 15 cases. Mod Pathol. 2001 May; 14(5):389-96. PMID: 11353047

Reddy SI, Farraye FA, Sapp H, Odze RD et. al. Clinical significance of unusual inflammatory bowel disease-like pathologic features in lymphocytic and cellagenous colitis. Gastroenterology. 2001; 120(5). View Publication
Mutinga ML, Farraye FA, Wang HH, Odze RD. Clinical significance of right colonic inflammation in patients with left sided chronic ulcerative colitis: A study of 34 patients. Gastroenterology. 2001; 120(5). View Publication
Stockwell DH, Woo P, Jacobson BC, Syngal S, Remily RM, Wolf J, Farraye FA. Rates of Colorectal Cancer screening in women undergoing mammography increase with knowledge of the adenoma-carcinoma sequence. Gastroenterology. 2001; 120(5). View Publication

Syngal S, Schrag D, Falchuk M, Tung N, Farraye FA, Chung D, Wright M, Whetsell A, Miller G, Garber JE. Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps. JAMA. 2000 Aug 16; 284(7):857-60. PMID: 10938175

Mutinga M, Castells M, Horan R, Farraye FA. Successful desensitization to 6-mercaptopurine in a patient with Crohn's disease. Am J Gastroenterol. 2000 May; 95(5):1383-4. PMID: 10811376

Lee JH, Paterson J, Greisman H, Jacobsen D, Farraye FA. Asymptomatic ileal carcinoid detected during colonoscopy. Am J Gastroenterol. 2000 Mar; 95(3):851-2. PMID: 10710115

Abowarda M, Farraye FA, Wallace M. Why are women more likely than men to have a limited screening flexible sigmoidoscopy? A study of 3701 patients. Gastroenterology. 2000; 118(4). View Publication
Lee JH, Johannes RS, Van Dam J, Farraye FA, Carr-Locke DI. 7125 How best to diagnose ipmt. Gastrointestinal Endoscopy. 2000; 51(4):AB273. View Publication

Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999 Dec; 117(6):1288-94; discussion 1488-91. PMID: 10579969

Lee M, Kemp JA, Canning A, Egan C, Tataronis G, Farraye FA. A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy. Arch Intern Med. 1999 Oct 25; 159(19):2312-6. PMID: 10547171

Wallace MB, Kemp JA, Meyer F, Horton K, Reffel A, Christiansen CL, Farraye FA. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists. Am J Med. 1999 Sep; 107(3):214-8.View Related Profiles.

Reffel, Angela
Christiansen, Cindy
Farraye, Francis

PMID: 10492313

Farraye FA, Calleja JL, Albillos A. Is colonoscopy indicated for small adenomas found by screening flexible sigmoidoscopy? Gastrointest Endosc. 1999 Sep; 50(3):443-4; discussion 444-5. PMID: 10515719

Fletcher RH, Farraye FA. Screening flexible sigmoidoscopy: effectiveness is not enough. Gastroenterology. 1999 Aug; 117(2):486-8. PMID: 10419930

Rex DK, Chak A, Vasudeva R, Gross T, Lieberman D, Bhattacharya I, Sack E, Wiersema M, Farraye F, Wallace M, Barrido D, Cravens E, Zeabart L, Bjorkman D, Lemmel T, Buckley S. Prospective determination of distal colon findings in average-risk patients with proximal colon cancer. Gastrointest Endosc. 1999 Jun; 49(6):727-30. PMID: 10343217

Wallace MB, Farraye FA, Kemp JA. Colonoscopy for small adenomas. Ann Intern Med. 1999 Apr 20; 130(8):701. PMID: 10215574

Hullar TE, Sapers BL, Ridker PM, Jenkins RL, Huth TS, Farraye FA. Herbal toxicity and fatal hepatic failure. Am J Med. 1999 Feb; 106(2):267-8.View Related Profiles.

Sapers, Benjamin
Farraye, Francis

PMID: 10230761

Wallace MB, Kemp JA, Trnka YM, Donovan JM, Farraye FA. Is colonoscopy indicated for small adenomas found by screening flexible sigmoidoscopy? Ann Intern Med. 1998 Aug 15; 129(4):273-8. PMID: 9729179

Tham TC, Lichtenstein DR, Vandervoort J, Wong RC, Brooks D, Van Dam J, Ruymann F, Farraye F, Carr-Locke DL. Role of endoscopic retrograde cholangiopancreatography for suspected choledocholithiasis in patients undergoing laparoscopic cholecystectomy. Gastrointest Endosc. 1998 Jan; 47(1):50-6.View Related Profiles.

Lichtenstein, David
Farraye, Francis

PMID: 9468423

Wallace M, Ho KY, Trnka Y, Henderson C, Kemp JA, Farraye FA. Comparison of nurse practitioners/physician assistants to gastroenterologists in performing flexible sigmoidoscopy. Gastroenterology. 1998; 114(4). View Publication

Mohan V, Kemp JA, Lewine HE, Rabin M, Goldstein ML, Farraye FA. Diffuse mesenteric amyloidosis. Dig Dis Sci. 1997 May; 42(5):1079-82. PMID: 9149066

Tham TC, Vandervoort J, Wong RC, Lichtenstein DR, Van Dam J, Ruymann F, Farraye F, Carr-Locke DL. Therapeutic ERCP in outpatients. Gastrointest Endosc. 1997 Mar; 45(3):225-30.View Related Profiles.

Lichtenstein, David
Farraye, Francis

PMID: 9087827

Tenner S, Carr-Locke DL, Banks PA, Brooks DC, Van Dam J, Farraye FA, Turner JR, Lichtenstein DR. Intraductal mucin-hypersecreting neoplasm "mucinous ductal ectasia": endoscopic recognition and management. Am J Gastroenterol. 1996 Dec; 91(12):2548-54.View Related Profiles.

Lichtenstein, David
Farraye, Francis

PMID: 8946984

Tenner S, Wong RC, Carr-Locke D, Davis SK, Farraye FA. Toothpick ingestion as a cause of acute and chronic duodenal inflammation. Am J Gastroenterol. 1996 Sep; 91(9):1860-2. PMID: 8792719

Fleischer I, Bryant D, Spiegel J, Christian R, Farraye FA. Peristomal hidradenitis suppurativa. J Wound Ostomy Continence Nurs. 1996 May; 23(3):171-3. PMID: 8845907

Tham TC, Vandervoort J, Wong RCK, Lichtenstein DR, Van Dam J, Ruymann F, Farraye FA, Brooks DC, Carr-Locke DI. Experience with ERCP and intraoperative cholangiography in 1847 patients undergoing laparoscopic cholecystectomy in a single center. Gastrointestinal Endoscopy. 1996; 43(4):399. View Publication

Brown RS, Peppercorn MA, Farraye FA, Glotzer DJ, Antonioli DA, Taylor G. Carcinoid tumor of the esophagus. J Clin Gastroenterol. 1994 Dec; 19(4):338-9. PMID: 7876519

Block K, Braver JM, Farraye FA. Aeromonas infection and intramural intestinal hemorrhage as a cause of small bowel obstruction. Am J Gastroenterol. 1994 Oct; 89(10):1902-3. PMID: 7942696

Farraye FA, Peppercorn MA. Abdominal pain, angioedema, and angiotensin-converting enzyme inhibitors. Am J Gastroenterol. 1994 Jul; 89(7):1117-8. PMID: 8017381

Parsons WG, Shoji BT, Farraye FA. Mesenteric venous thrombosis mimicking rectal carcinoma and presenting as a distal large bowel obstruction. Am J Gastroenterol. 1994 Jul; 89(7):1126-7. PMID: 8017390

Eng C, Farraye FA, Shulman LN, Peppercorn MA, Krauss CM, Connors JM, Stone RM. The association between the myelodysplastic syndromes and Crohn disease. Ann Intern Med. 1992 Oct 15; 117(8):661-2. PMID: 1530197

Nompleggi DJ, Farraye FA, Singer A, Edelman RR, Chopra S. Hepatic schistosomiasis: report of two cases and literature review. Am J Gastroenterol. 1991 Nov; 86(11):1658-64. PMID: 1951247

Berg CL, Farraye FR, Carr-Locke DL. Tube cecostomy as a cause of cecal pseudotumor. Endoscopy. 1991 Jul; 23(4):229-30. PMID: 1915141; DOI: 10.1055/s-2007-1010664;

Van Dam J, Farraye FA, Gale RP, Zeldis JB. Fulminant hepatic failure following bone marrow transplantation for hepatitis-associated aplastic anemia. Bone Marrow Transplant. 1990 Jan; 5(1):57-60. PMID: 2105142

Farraye FA, Mamish DM, Zeldis JB. Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients. J Med Virol. 1989 Dec; 29(4):266-7. PMID: 2621453

Farraye FA, Peppercorn MA, Ciano PS, Kavesh WN. Segmental colitis associated with Aeromonas hydrophila. Am J Gastroenterol. 1989 Apr; 84(4):436-8. PMID: 2929569

Blumberg RS, Chopra S, Ibrahim R, Crawford J, Farraye FA, Zeldis JB, Berman MD. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology. 1988 Nov; 95(5):1399-402. PMID: 2844622

Zeldis JB, Farraye FA, Steinberg HN. In vitro hepatitis B virus suppression of erythropoiesis is dependent on the multiplicity of infection and is reversible with anti-HBs antibodies. Hepatology. 1988 Jul-Aug; 8(4):755-9. PMID: 3391504

Farraye FA, Peppercorn MA, Steer ML, Joffe N, Rees M. Acute small-bowel mucosal edema following enalapril use. JAMA. 1988 Jun 3; 259(21):3131. PMID: 2835523

Farraye FA, Zeldis JB. Thein vitro production of Dane-like particles: Is it live or memorex?. Hepatology. 1987; 7(3):601-603. View Publication
Farraye FA. Diagnosis and Management of Flat and Polypoid Dysplasia in Inflammatory Bowel Disease.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 472 publications over 36 distinct years, with a maximum of 39 publications in 2021 and 2023

Bar chart showing 472 publications over 36 distinct years, with a maximum of 39 publications in 2021 and 2023

Year	Publications
1987	1
1988	3
1989	2
1990	1
1991	2
1992	1
1994	4
1996	4
1997	2
1998	3
1999	8
2000	5
2001	8
2002	11
2003	14
2004	15
2005	14
2006	14
2007	6
2008	18
2009	16
2010	26
2011	20
2012	9
2013	23
2014	17
2015	17
2016	24
2017	19
2018	10
2019	17
2020	18
2021	39
2022	29
2023	39
2024	13